ID

DB08953||

名称

Indalpine

描述

Indalpine was one of the first selective serotonin reuptake inhibitors to reach the American market. It was initially marketed by Pharmuka. However, after the emergence of widespread concern regarding adverse effects caused by SSRIs, and reported hematological effects caused by Indalpine, it was abruptly withdrawn from the US market.

cas号

63758-79-2

唯一标识码

V35562QSVT

状态

solid

组

investigational,withdrawn,

指示

药效学

作用机制

毒性

代谢

吸收

半衰期

分类

description:This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.
direct-parent:3-alkylindoles
kingdom:Organic compounds
superclass:Organoheterocyclic compounds
class:Indoles and derivatives
subclass:Indoles
alternative-parent:Aralkylamines
alternative-parent:Azacyclic compounds
alternative-parent:Benzenoids
alternative-parent:Dialkylamines
alternative-parent:Heteroaromatic compounds
alternative-parent:Hydrocarbon derivatives
alternative-parent:Organopnictogen compounds
alternative-parent:Piperidines
alternative-parent:Substituted pyrroles
substituent:3-alkylindole
substituent:Amine
substituent:Aralkylamine
substituent:Aromatic heteropolycyclic compound
substituent:Azacycle
substituent:Benzenoid
substituent:Heteroaromatic compound
substituent:Hydrocarbon derivative
substituent:Organic nitrogen compound
substituent:Organonitrogen compound
substituent:Organopnictogen compound
substituent:Piperidine
substituent:Pyrrole
substituent:Secondary aliphatic amine
substituent:Secondary amine
substituent:Substituted pyrrole

消除途径

种类

Antidepressive Agents
D000928
Central Nervous System Agents
D002491
Central Nervous System Depressants
D002492
Cytochrome P-450 CYP3A Inhibitors
D065692
Cytochrome P-450 CYP3A Substrates

Cytochrome P-450 CYP3A4 Inhibitors
D065692
Cytochrome P-450 CYP3A4 Inhibitors (moderate)

Cytochrome P-450 CYP3A4 Substrates

Cytochrome P-450 Enzyme Inhibitors
D065607
Cytochrome P-450 Substrates

Hypoglycemia-Associated Agents

Membrane Transport Modulators
D049990
Neurotransmitter Agents
D018377
Neurotransmitter Uptake Inhibitors
D014179
Psychotropic Drugs
D011619
Selective Serotonin Reuptake Inhibitors
D017367
Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
D020230
Serotonin Agents
D018490
Serotonin Modulators

盐类

蛋白质结合

清除

同义词

国际品牌

UpstènePharmuka

配送量

产品

混合物

包装者

生产者

价格

受影响的生物体

剂量

atc代码

fda标签

化学品安全技术说明书

专利

食物相互作用

药物相互作用

DB00434
The therapeutic efficacy of Indalpine can be decreased when used in combination with Cyproheptadine.
DB00035
The risk or severity of hyponatremia can be increased when Indalpine is combined with Desmopressin.
DB08824
Indalpine may decrease effectiveness of Ioflupane I-123 as a diagnostic agent.
DB00601
The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Indalpine.
DB00765
The risk or severity of extrapyramidal symptoms can be increased when Metyrosine is combined with Indalpine.
DB01100
The risk or severity of QTc prolongation can be increased when Indalpine is combined with Pimozide.
DB00921
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
DB00366
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Indalpine.
DB00470
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Indalpine.
DB00450
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Indalpine.
DB00956
Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Indalpine.
DB00557
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Indalpine.
DB00653
The therapeutic efficacy of Indalpine can be increased when used in combination with Magnesium sulfate.
DB01403
Methotrimeprazine may increase the central nervous system depressant (CNS depressant) activities of Indalpine.
DB01017
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Indalpine.
DB00486
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Indalpine.
DB01173
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
DB09117
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
DB08883
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Indalpine.
DB00413
Indalpine may increase the sedative activities of Pramipexole.
DB00268
Indalpine may increase the sedative activities of Ropinirole.
DB05271
Indalpine may increase the sedative activities of Rotigotine.
DB06201
The risk or severity of adverse effects can be increased when Rufinamide is combined with Indalpine.
DB09072
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Indalpine.
DB09034
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
DB06204
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Indalpine.
DB01041
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
DB00425
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
DB09128
The metabolism of Brexpiprazole can be decreased when combined with Indalpine.
DB09039
The metabolism of Eliglustat can be decreased when combined with Indalpine.
DB01590
The metabolism of Everolimus can be decreased when combined with Indalpine.
DB04908
The metabolism of Flibanserin can be decreased when combined with Indalpine.
DB09053
The metabolism of Ibrutinib can be decreased when combined with Indalpine.
DB09083
The metabolism of Ivabradine can be decreased when combined with Indalpine.
DB08820
The metabolism of Ivacaftor can be decreased when combined with Indalpine.
DB08815
The metabolism of Lurasidone can be decreased when combined with Indalpine.
DB09049
The metabolism of Naloxegol can be decreased when combined with Indalpine.
DB09074
The metabolism of Olaparib can be decreased when combined with Indalpine.
DB00243
The metabolism of Ranolazine can be decreased when combined with Indalpine.
DB09143
The metabolism of Sonidegib can be decreased when combined with Indalpine.
DB06237
The metabolism of Avanafil can be decreased when combined with Indalpine.
DB00700
The metabolism of Eplerenone can be decreased when combined with Indalpine.
DB01166
The metabolism of Cilostazol can be decreased when combined with Indalpine.
DB01394
The metabolism of Colchicine can be decreased when combined with Indalpine.
DB00813
The metabolism of Fentanyl can be decreased when combined with Indalpine.
DB04946
The metabolism of Iloperidone can be decreased when combined with Indalpine.
DB01256
The metabolism of Retapamulin can be decreased when combined with Indalpine.
DB08895
The metabolism of Tofacitinib can be decreased when combined with Indalpine.
DB00862
The metabolism of Vardenafil can be decreased when combined with Indalpine.
DB01198
The metabolism of Zopiclone can be decreased when combined with Indalpine.
DB00227
The metabolism of Lovastatin can be decreased when combined with Indalpine.
DB00333
The risk or severity of adverse effects can be increased when Methadone is combined with Indalpine.
DB00346
The metabolism of Alfuzosin can be decreased when combined with Indalpine.
DB00404
The metabolism of Alprazolam can be decreased when combined with Indalpine.
DB00682
The serum concentration of Warfarin can be increased when it is combined with Indalpine.
DB01418
The serum concentration of Acenocoumarol can be increased when it is combined with Indalpine.
DB08496
The serum concentration of (R)-warfarin can be increased when it is combined with Indalpine.
DB08735
The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Indalpine.
DB08736
The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Indalpine.
DB14055
The serum concentration of (S)-Warfarin can be increased when it is combined with Indalpine.
DB00683
The serum concentration of Midazolam can be increased when it is combined with Indalpine.
DB00864
The serum concentration of Tacrolimus can be increased when it is combined with Indalpine.
DB01076
The metabolism of Atorvastatin can be decreased when combined with Indalpine.
DB09042
The risk or severity of serotonin syndrome can be increased when Tedizolid phosphate is combined with Indalpine.
DB00370
Indalpine may increase the serotonergic activities of Mirtazapine.
DB00295
The risk or severity of serotonin syndrome can be increased when Morphine is combined with Indalpine.
DB00318
The risk or severity of serotonin syndrome can be increased when Codeine is combined with Indalpine.
DB00327
The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Indalpine.
DB00497
The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Indalpine.
DB00611
The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Indalpine.
DB00647
The risk or severity of serotonin syndrome can be increased when Dextropropoxyphene is combined with Indalpine.
DB00652
The risk or severity of serotonin syndrome can be increased when Pentazocine is combined with Indalpine.
DB00708
The risk or severity of serotonin syndrome can be increased when Sufentanil is combined with Indalpine.
DB00844
The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Indalpine.
DB00854
The risk or severity of serotonin syndrome can be increased when Levorphanol is combined with Indalpine.
DB00899
The risk or severity of serotonin syndrome can be increased when Remifentanil is combined with Indalpine.
DB01081
The risk or severity of serotonin syndrome can be increased when Diphenoxylate is combined with Indalpine.
DB01192
The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Indalpine.
DB01209
The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Indalpine.
DB01433
The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Indalpine.
DB01450
The risk or severity of serotonin syndrome can be increased when Dihydroetorphine is combined with Indalpine.
DB01452
The risk or severity of serotonin syndrome can be increased when Diamorphine is combined with Indalpine.
DB01466
The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Indalpine.
DB01497
The risk or severity of serotonin syndrome can be increased when Etorphine is combined with Indalpine.
DB01529
The risk or severity of serotonin syndrome can be increased when Dextromoramide is combined with Indalpine.
DB01531
The risk or severity of serotonin syndrome can be increased when Desomorphine is combined with Indalpine.
DB01535
The risk or severity of serotonin syndrome can be increased when Carfentanil is combined with Indalpine.
DB01551
The risk or severity of serotonin syndrome can be increased when Dihydrocodeine is combined with Indalpine.
DB01555
The risk or severity of serotonin syndrome can be increased when Alphacetylmethadol is combined with Indalpine.
DB01565
The risk or severity of serotonin syndrome can be increased when Dihydromorphine is combined with Indalpine.
DB06738
The risk or severity of serotonin syndrome can be increased when Ketobemidone is combined with Indalpine.
DB08861
The risk or severity of serotonin syndrome can be increased when DPDPE is combined with Indalpine.
DB09174
The risk or severity of serotonin syndrome can be increased when Lofentanil is combined with Indalpine.
DB11130
The risk or severity of serotonin syndrome can be increased when Opium is combined with Indalpine.
DB11609
The risk or severity of serotonin syndrome can be increased when Normethadone is combined with Indalpine.
DB12492
The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Indalpine.
DB13160
The risk or severity of serotonin syndrome can be increased when Alphaprodine is combined with Indalpine.
DB13478
The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Indalpine.
DB13605
The risk or severity of serotonin syndrome can be increased when Phenoperidine is combined with Indalpine.
DB13606
The risk or severity of serotonin syndrome can be increased when Phenazocine is combined with Indalpine.
DB13787
The risk or severity of serotonin syndrome can be increased when Tilidine is combined with Indalpine.
DB15360
The risk or severity of serotonin syndrome can be increased when Carfentanil, C-11 is combined with Indalpine.
DB00704
The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Indalpine.
DB01459
The risk or severity of serotonin syndrome can be increased when Bezitramide is combined with Indalpine.
DB09272
The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Eluxadoline.
DB13454
The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Nicomorphine.
DB00454
The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Meperidine.
DB00802
The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Alfentanil.
DB01227
The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Levacetylmethadol.
DB15465
The risk or severity of serotonin syndrome can be increased when Benzhydrocodone is combined with Indalpine.
DB06704
Indalpine may decrease effectiveness of Iobenguane as a diagnostic agent.
DB00232
The risk or severity of hyponatremia can be increased when Indalpine is combined with Methyclothiazide.
DB00310
The risk or severity of hyponatremia can be increased when Indalpine is combined with Chlorthalidone.
DB00436
The risk or severity of hyponatremia can be increased when Indalpine is combined with Bendroflumethiazide.
DB00524
The risk or severity of hyponatremia can be increased when Indalpine is combined with Metolazone.
DB00562
The risk or severity of hyponatremia can be increased when Indalpine is combined with Benzthiazide.
DB00774
The risk or severity of hyponatremia can be increased when Indalpine is combined with Hydroflumethiazide.
DB00808
The risk or severity of hyponatremia can be increased when Indalpine is combined with Indapamide.
DB00880
The risk or severity of hyponatremia can be increased when Indalpine is combined with Chlorothiazide.
DB00999
The risk or severity of hyponatremia can be increased when Indalpine is combined with Hydrochlorothiazide.
DB01021
The risk or severity of hyponatremia can be increased when Indalpine is combined with Trichlormethiazide.
DB01324
The risk or severity of hyponatremia can be increased when Indalpine is combined with Polythiazide.
DB01325
The risk or severity of hyponatremia can be increased when Indalpine is combined with Quinethazone.
DB13532
The risk or severity of hyponatremia can be increased when Indalpine is combined with Cyclopenthiazide.
DB13989
The risk or severity of hyponatremia can be increased when Indalpine is combined with Epitizide.
DB00898
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
DB00972
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
DB00484
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Indalpine.
DB00042
The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Indalpine.
DB00083
The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Indalpine.
DB00181
The risk or severity of adverse effects can be increased when Baclofen is combined with Indalpine.
DB00189
The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Indalpine.
DB00202
The risk or severity of adverse effects can be increased when Succinylcholine is combined with Indalpine.
DB00228
The risk or severity of adverse effects can be increased when Enflurane is combined with Indalpine.
DB00237
The risk or severity of adverse effects can be increased when Butabarbital is combined with Indalpine.
DB00241
The risk or severity of adverse effects can be increased when Butalbital is combined with Indalpine.
DB00283
The risk or severity of adverse effects can be increased when Clemastine is combined with Indalpine.
DB00289
The risk or severity of adverse effects can be increased when Atomoxetine is combined with Indalpine.
DB00292
The risk or severity of adverse effects can be increased when Etomidate is combined with Indalpine.
DB00306
The risk or severity of adverse effects can be increased when Talbutal is combined with Indalpine.
DB00323
The risk or severity of adverse effects can be increased when Tolcapone is combined with Indalpine.
DB00341
The risk or severity of adverse effects can be increased when Cetirizine is combined with Indalpine.
DB00347
The risk or severity of adverse effects can be increased when Trimethadione is combined with Indalpine.
DB00356
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Indalpine.
DB00372
The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Indalpine.
DB00377
The risk or severity of adverse effects can be increased when Palonosetron is combined with Indalpine.
DB00405
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Indalpine.
DB00416
The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Indalpine.
DB00418
The risk or severity of adverse effects can be increased when Secobarbital is combined with Indalpine.
DB00423
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Indalpine.
DB00427
The risk or severity of adverse effects can be increased when Triprolidine is combined with Indalpine.
DB00463
The risk or severity of adverse effects can be increased when Metharbital is combined with Indalpine.
DB00474
The risk or severity of adverse effects can be increased when Methohexital is combined with Indalpine.
DB00483
The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Indalpine.
DB00494
The risk or severity of adverse effects can be increased when Entacapone is combined with Indalpine.
DB00514
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Indalpine.
DB00532
The risk or severity of adverse effects can be increased when Mephenytoin is combined with Indalpine.
DB00565
The risk or severity of adverse effects can be increased when Cisatracurium is combined with Indalpine.
DB00579
The risk or severity of adverse effects can be increased when Mazindol is combined with Indalpine.
DB00588
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Indalpine.
DB00589
The risk or severity of adverse effects can be increased when Lisuride is combined with Indalpine.
DB00599
The risk or severity of adverse effects can be increased when Thiopental is combined with Indalpine.
DB00617
The risk or severity of adverse effects can be increased when Paramethadione is combined with Indalpine.
DB00633
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Indalpine.
DB00645
The risk or severity of adverse effects can be increased when Dyclonine is combined with Indalpine.
DB00660
The risk or severity of adverse effects can be increased when Metaxalone is combined with Indalpine.
DB00662
The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Indalpine.
DB00680
The risk or severity of adverse effects can be increased when Moricizine is combined with Indalpine.
DB00697
The risk or severity of adverse effects can be increased when Tizanidine is combined with Indalpine.
DB00714
The risk or severity of adverse effects can be increased when Apomorphine is combined with Indalpine.
DB00728
The risk or severity of adverse effects can be increased when Rocuronium is combined with Indalpine.
DB00732
The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Indalpine.
DB00737
The risk or severity of adverse effects can be increased when Meclizine is combined with Indalpine.
DB00740
The risk or severity of adverse effects can be increased when Riluzole is combined with Indalpine.
DB00747
The risk or severity of adverse effects can be increased when Scopolamine is combined with Indalpine.
DB00748
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Indalpine.
DB00753
The risk or severity of adverse effects can be increased when Isoflurane is combined with Indalpine.
DB00754
The risk or severity of adverse effects can be increased when Ethotoin is combined with Indalpine.
DB00757
The risk or severity of adverse effects can be increased when Dolasetron is combined with Indalpine.
DB00771
The risk or severity of adverse effects can be increased when Clidinium is combined with Indalpine.
DB00777
The risk or severity of adverse effects can be increased when Propiomazine is combined with Indalpine.
DB00818
The risk or severity of adverse effects can be increased when Propofol is combined with Indalpine.
DB00819
The risk or severity of adverse effects can be increased when Acetazolamide is combined with Indalpine.
DB00832
The risk or severity of adverse effects can be increased when Phensuximide is combined with Indalpine.
DB00835
The risk or severity of adverse effects can be increased when Brompheniramine is combined with Indalpine.
DB00843
The risk or severity of adverse effects can be increased when Donepezil is combined with Indalpine.
DB00849
The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Indalpine.
DB00865
The risk or severity of adverse effects can be increased when Benzphetamine is combined with Indalpine.
DB00866
The risk or severity of adverse effects can be increased when Alprenolol is combined with Indalpine.
DB00889
The risk or severity of adverse effects can be increased when Granisetron is combined with Indalpine.
DB00906
The risk or severity of adverse effects can be increased when Tiagabine is combined with Indalpine.
DB00909
The risk or severity of adverse effects can be increased when Zonisamide is combined with Indalpine.
DB00918
The risk or severity of adverse effects can be increased when Almotriptan is combined with Indalpine.
DB00941
The risk or severity of adverse effects can be increased when Hexafluronium is combined with Indalpine.
DB00949
The risk or severity of adverse effects can be increased when Felbamate is combined with Indalpine.
DB00952
The risk or severity of adverse effects can be increased when Naratriptan is combined with Indalpine.
DB00960
The risk or severity of adverse effects can be increased when Pindolol is combined with Indalpine.
DB00962
The risk or severity of adverse effects can be increased when Zaleplon is combined with Indalpine.
DB00967
The risk or severity of adverse effects can be increased when Desloratadine is combined with Indalpine.
DB00969
The risk or severity of adverse effects can be increased when Alosetron is combined with Indalpine.
DB00980
The risk or severity of adverse effects can be increased when Ramelteon is combined with Indalpine.
DB00985
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Indalpine.
DB00998
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Indalpine.
DB01018
The risk or severity of adverse effects can be increased when Guanfacine is combined with Indalpine.
DB01028
The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Indalpine.
DB01049
The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Indalpine.
DB01063
The risk or severity of adverse effects can be increased when Acetophenazine is combined with Indalpine.
DB01065
The risk or severity of adverse effects can be increased when Melatonin is combined with Indalpine.
DB01068
The risk or severity of adverse effects can be increased when Clonazepam is combined with Indalpine.
DB01069
The risk or severity of adverse effects can be increased when Promethazine is combined with Indalpine.
DB01075
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Indalpine.
DB01080
The risk or severity of adverse effects can be increased when Vigabatrin is combined with Indalpine.
DB01106
The risk or severity of adverse effects can be increased when Levocabastine is combined with Indalpine.
DB01107
The risk or severity of adverse effects can be increased when Methyprylon is combined with Indalpine.
DB01114
The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Indalpine.
DB01121
The risk or severity of adverse effects can be increased when Phenacemide is combined with Indalpine.
DB01135
The risk or severity of adverse effects can be increased when Doxacurium is combined with Indalpine.
DB01154
The risk or severity of adverse effects can be increased when Thiamylal is combined with Indalpine.
DB01159
The risk or severity of adverse effects can be increased when Halothane is combined with Indalpine.
DB01176
The risk or severity of adverse effects can be increased when Cyclizine is combined with Indalpine.
DB01186
The risk or severity of adverse effects can be increased when Pergolide is combined with Indalpine.
DB01189
The risk or severity of adverse effects can be increased when Desflurane is combined with Indalpine.
DB01199
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Indalpine.
DB01202
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Indalpine.
DB01219
The risk or severity of adverse effects can be increased when Dantrolene is combined with Indalpine.
DB01221
The risk or severity of adverse effects can be increased when Ketamine is combined with Indalpine.
DB01226
The risk or severity of adverse effects can be increased when Mivacurium is combined with Indalpine.
DB01235
The risk or severity of adverse effects can be increased when Levodopa is combined with Indalpine.
DB01236
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Indalpine.
DB01245
The risk or severity of adverse effects can be increased when Decamethonium is combined with Indalpine.
DB01246
The risk or severity of adverse effects can be increased when Alimemazine is combined with Indalpine.
DB01253
The risk or severity of adverse effects can be increased when Ergometrine is combined with Indalpine.
DB01336
The risk or severity of adverse effects can be increased when Metocurine is combined with Indalpine.
DB01337
The risk or severity of adverse effects can be increased when Pancuronium is combined with Indalpine.
DB01338
The risk or severity of adverse effects can be increased when Pipecuronium is combined with Indalpine.
DB01339
The risk or severity of adverse effects can be increased when Vecuronium is combined with Indalpine.
DB01351
The risk or severity of adverse effects can be increased when Amobarbital is combined with Indalpine.
DB01352
The risk or severity of adverse effects can be increased when Aprobarbital is combined with Indalpine.
DB01353
The risk or severity of adverse effects can be increased when Butobarbital is combined with Indalpine.
DB01354
The risk or severity of adverse effects can be increased when Heptabarbital is combined with Indalpine.
DB01355
The risk or severity of adverse effects can be increased when Hexobarbital is combined with Indalpine.
DB01359
The risk or severity of adverse effects can be increased when Penbutolol is combined with Indalpine.
DB01392
The risk or severity of adverse effects can be increased when Yohimbine is combined with Indalpine.
DB01437
The risk or severity of adverse effects can be increased when Glutethimide is combined with Indalpine.
DB01440
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Indalpine.
DB01442
The risk or severity of adverse effects can be increased when MMDA is combined with Indalpine.
DB01483
The risk or severity of adverse effects can be increased when Barbital is combined with Indalpine.
DB01489
The risk or severity of adverse effects can be increased when Camazepam is combined with Indalpine.
DB01495
The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Indalpine.
DB01501
The risk or severity of adverse effects can be increased when Difenoxin is combined with Indalpine.
DB01511
The risk or severity of adverse effects can be increased when Delorazepam is combined with Indalpine.
DB01534
The risk or severity of adverse effects can be increased when Chlorhexadol is combined with Indalpine.
DB01547
The risk or severity of adverse effects can be increased when Drotebanol is combined with Indalpine.
DB01553
The risk or severity of adverse effects can be increased when Cloxazolam is combined with Indalpine.
DB01559
The risk or severity of adverse effects can be increased when Clotiazepam is combined with Indalpine.
DB01563
The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Indalpine.
DB01577
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Indalpine.
DB01580
The risk or severity of adverse effects can be increased when Oxprenolol is combined with Indalpine.
DB01589
The risk or severity of adverse effects can be increased when Quazepam is combined with Indalpine.
DB01594
The risk or severity of adverse effects can be increased when Cinolazepam is combined with Indalpine.
DB01608
The risk or severity of adverse effects can be increased when Periciazine is combined with Indalpine.
DB01616
The risk or severity of adverse effects can be increased when Alverine is combined with Indalpine.
DB01621
The risk or severity of adverse effects can be increased when Pipotiazine is combined with Indalpine.
DB01622
The risk or severity of adverse effects can be increased when Thioproperazine is combined with Indalpine.
DB02234
The risk or severity of adverse effects can be increased when S-Ethylisothiourea is combined with Indalpine.
DB02852
The risk or severity of adverse effects can be increased when Domoic Acid is combined with Indalpine.
DB04165
The risk or severity of adverse effects can be increased when Valpromide is combined with Indalpine.
DB04819
The risk or severity of adverse effects can be increased when Methapyrilene is combined with Indalpine.
DB04821
The risk or severity of adverse effects can be increased when Nomifensine is combined with Indalpine.
DB04827
The risk or severity of adverse effects can be increased when Urethane is combined with Indalpine.
DB04832
The risk or severity of adverse effects can be increased when Zimelidine is combined with Indalpine.
DB04833
The risk or severity of adverse effects can be increased when Methaqualone is combined with Indalpine.
DB04834
The risk or severity of adverse effects can be increased when Rapacuronium is combined with Indalpine.
DB04841
The risk or severity of adverse effects can be increased when Flunarizine is combined with Indalpine.
DB04871
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Indalpine.
DB04884
The risk or severity of adverse effects can be increased when Dapoxetine is combined with Indalpine.
DB04885
The risk or severity of adverse effects can be increased when Cilansetron is combined with Indalpine.
DB04888
The risk or severity of adverse effects can be increased when Bifeprunox is combined with Indalpine.
DB04903
The risk or severity of adverse effects can be increased when Pagoclone is combined with Indalpine.
DB04917
The risk or severity of adverse effects can be increased when Renzapride is combined with Indalpine.
DB04953
The risk or severity of adverse effects can be increased when Ezogabine is combined with Indalpine.
DB05227
The risk or severity of adverse effects can be increased when APD791 is combined with Indalpine.
DB05232
The risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Indalpine.
DB05246
The risk or severity of adverse effects can be increased when Methsuximide is combined with Indalpine.
DB05541
The risk or severity of adverse effects can be increased when Brivaracetam is combined with Indalpine.
DB05542
The risk or severity of adverse effects can be increased when Naronapride is combined with Indalpine.
DB05562
The risk or severity of adverse effects can be increased when Naluzotan is combined with Indalpine.
DB05607
The risk or severity of adverse effects can be increased when PRX-08066 is combined with Indalpine.
DB05687
The risk or severity of adverse effects can be increased when BL-1020 is combined with Indalpine.
DB05710
The risk or severity of adverse effects can be increased when Gantacurium is combined with Indalpine.
DB06109
The risk or severity of adverse effects can be increased when YKP-1358 is combined with Indalpine.
DB06218
The risk or severity of adverse effects can be increased when Lacosamide is combined with Indalpine.
DB06264
The risk or severity of adverse effects can be increased when Tolperisone is combined with Indalpine.
DB06282
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Indalpine.
DB06283
The risk or severity of adverse effects can be increased when Ziconotide is combined with Indalpine.
DB06446
The risk or severity of adverse effects can be increased when Dotarizine is combined with Indalpine.
DB06458
The risk or severity of adverse effects can be increased when Remacemide is combined with Indalpine.
DB06470
The risk or severity of adverse effects can be increased when Clomethiazole is combined with Indalpine.
DB06527
The risk or severity of adverse effects can be increased when Tramiprosate is combined with Indalpine.
DB06529
The risk or severity of adverse effects can be increased when Ocinaplon is combined with Indalpine.
DB06554
The risk or severity of adverse effects can be increased when Gaboxadol is combined with Indalpine.
DB06594
The risk or severity of adverse effects can be increased when Agomelatine is combined with Indalpine.
DB06660
The risk or severity of adverse effects can be increased when Saredutant is combined with Indalpine.
DB06690
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Indalpine.
DB06691
The risk or severity of adverse effects can be increased when Mepyramine is combined with Indalpine.
DB06701
The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Indalpine.
DB06716
The risk or severity of adverse effects can be increased when Fospropofol is combined with Indalpine.
DB06731
The risk or severity of adverse effects can be increased when Seproxetine is combined with Indalpine.
DB06753
The risk or severity of adverse effects can be increased when Triclofos is combined with Indalpine.
DB06770
The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Indalpine.
DB06797
The risk or severity of adverse effects can be increased when Mebutamate is combined with Indalpine.
DB08059
The risk or severity of adverse effects can be increased when Wortmannin is combined with Indalpine.
DB08329
The risk or severity of adverse effects can be increased when Sulthiame is combined with Indalpine.
DB08810
The risk or severity of adverse effects can be increased when Cinitapride is combined with Indalpine.
DB08839
The risk or severity of adverse effects can be increased when Serotonin is combined with Indalpine.
DB08872
The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Indalpine.
DB08892
The risk or severity of adverse effects can be increased when Arbaclofen Placarbil is combined with Indalpine.
DB08954
The risk or severity of adverse effects can be increased when Ifenprodil is combined with Indalpine.
DB08960
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Indalpine.
DB08992
The risk or severity of adverse effects can be increased when Eperisone is combined with Indalpine.
DB08996
The risk or severity of adverse effects can be increased when Dimetacrine is combined with Indalpine.
DB09000
The risk or severity of adverse effects can be increased when Cyamemazine is combined with Indalpine.
DB09001
The risk or severity of adverse effects can be increased when Barbexaclone is combined with Indalpine.
DB09011
The risk or severity of adverse effects can be increased when Beclamide is combined with Indalpine.
DB09014
The risk or severity of adverse effects can be increased when Captodiame is combined with Indalpine.
DB09017
The risk or severity of adverse effects can be increased when Brotizolam is combined with Indalpine.
DB09021
The risk or severity of adverse effects can be increased when Benzoctamine is combined with Indalpine.
DB09071
The risk or severity of adverse effects can be increased when Tasimelteon is combined with Indalpine.
DB09119
The risk or severity of adverse effects can be increased when Eslicarbazepine acetate is combined with Indalpine.
DB09184
The risk or severity of adverse effects can be increased when Edivoxetine is combined with Indalpine.
DB09186
The risk or severity of adverse effects can be increased when Nisoxetine is combined with Indalpine.
DB09187
The risk or severity of adverse effects can be increased when Lortalamine is combined with Indalpine.
DB09190
The risk or severity of adverse effects can be increased when Talopram is combined with Indalpine.
DB09194
The risk or severity of adverse effects can be increased when Etoperidone is combined with Indalpine.
DB09223
The risk or severity of adverse effects can be increased when Blonanserin is combined with Indalpine.
DB09247
The risk or severity of adverse effects can be increased when Iproclozide is combined with Indalpine.
DB09290
The risk or severity of adverse effects can be increased when Ramosetron is combined with Indalpine.
DB11156
The risk or severity of adverse effects can be increased when Pyrantel is combined with Indalpine.
DB11371
The risk or severity of adverse effects can be increased when Alfaxalone is combined with Indalpine.
DB11400
The risk or severity of adverse effects can be increased when Doramectin is combined with Indalpine.
DB11428
The risk or severity of adverse effects can be increased when Medetomidine is combined with Indalpine.
DB11477
The risk or severity of adverse effects can be increased when Xylazine is combined with Indalpine.
DB11540
The risk or severity of adverse effects can be increased when Propiopromazine is combined with Indalpine.
DB11543
The risk or severity of adverse effects can be increased when Romifidine is combined with Indalpine.
DB11549
The risk or severity of adverse effects can be increased when Tiletamine is combined with Indalpine.
DB11552
The risk or severity of adverse effects can be increased when Tricaine is combined with Indalpine.
DB11556
The risk or severity of adverse effects can be increased when Detomidine is combined with Indalpine.
DB11582
The risk or severity of adverse effects can be increased when Thiocolchicoside is combined with Indalpine.
DB11675
The risk or severity of adverse effects can be increased when Mosapride is combined with Indalpine.
DB11686
The risk or severity of adverse effects can be increased when Iferanserin is combined with Indalpine.
DB11699
The risk or severity of adverse effects can be increased when Tropisetron is combined with Indalpine.
DB11755
The risk or severity of adverse effects can be increased when Tetrahydrocannabivarin is combined with Indalpine.
DB11859
The risk or severity of adverse effects can be increased when Brexanolone is combined with Indalpine.
DB11868
The risk or severity of adverse effects can be increased when Etiracetam is combined with Indalpine.
DB11889
The risk or severity of adverse effects can be increased when Lanicemine is combined with Indalpine.
DB11957
The risk or severity of adverse effects can be increased when Idalopirdine is combined with Indalpine.
DB12071
The risk or severity of adverse effects can be increased when Vabicaserin is combined with Indalpine.
DB12105
The risk or severity of adverse effects can be increased when Imagabalin is combined with Indalpine.
DB12110
The risk or severity of adverse effects can be increased when m-Chlorophenylpiperazine is combined with Indalpine.
DB12111
The risk or severity of adverse effects can be increased when MK-212 is combined with Indalpine.
DB12131
The risk or severity of adverse effects can be increased when Vinpocetine is combined with Indalpine.
DB12163
The risk or severity of adverse effects can be increased when Sarpogrelate is combined with Indalpine.
DB12177
The risk or severity of adverse effects can be increased when Eplivanserin is combined with Indalpine.
DB12229
The risk or severity of adverse effects can be increased when Cerlapirdine is combined with Indalpine.
DB12308
The risk or severity of adverse effects can be increased when Eltanolone is combined with Indalpine.
DB12338
The risk or severity of adverse effects can be increased when Carisbamate is combined with Indalpine.
DB12361
The risk or severity of adverse effects can be increased when Piclozotan is combined with Indalpine.
DB12395
The risk or severity of adverse effects can be increased when Esreboxetine is combined with Indalpine.
DB12427
The risk or severity of adverse effects can be increased when Orvepitant is combined with Indalpine.
DB12465
The risk or severity of adverse effects can be increased when Ketanserin is combined with Indalpine.
DB12537
The risk or severity of adverse effects can be increased when Benzodiazepine is combined with Indalpine.
DB12576
The risk or severity of adverse effects can be increased when AZD-3043 is combined with Indalpine.
DB12590
The risk or severity of adverse effects can be increased when Indiplon is combined with Indalpine.
DB12661
The risk or severity of adverse effects can be increased when Urapidil is combined with Indalpine.
DB12725
The risk or severity of adverse effects can be increased when TD-8954 is combined with Indalpine.
DB12883
The risk or severity of adverse effects can be increased when Eltoprazine is combined with Indalpine.
DB12951
The risk or severity of adverse effects can be increased when Pivagabine is combined with Indalpine.
DB12958
The risk or severity of adverse effects can be increased when Prothipendyl is combined with Indalpine.
DB12989
The risk or severity of adverse effects can be increased when Neosaxitoxin is combined with Indalpine.
DB13099
The risk or severity of adverse effects can be increased when Valnoctamide is combined with Indalpine.
DB13114
The risk or severity of adverse effects can be increased when Amitriptylinoxide is combined with Indalpine.
DB13213
The risk or severity of adverse effects can be increased when Butaperazine is combined with Indalpine.
DB13219
The risk or severity of adverse effects can be increased when Medifoxamine is combined with Indalpine.
DB13221
The risk or severity of adverse effects can be increased when Apronalide is combined with Indalpine.
DB13234
The risk or severity of adverse effects can be increased when Propanidid is combined with Indalpine.
DB13246
The risk or severity of adverse effects can be increased when Quinupramine is combined with Indalpine.
DB13253
The risk or severity of adverse effects can be increased when Proxibarbal is combined with Indalpine.
DB13295
The risk or severity of adverse effects can be increased when Atracurium is combined with Indalpine.
DB13303
The risk or severity of adverse effects can be increased when Febarbamate is combined with Indalpine.
DB13323
The risk or severity of adverse effects can be increased when Trichloroethylene is combined with Indalpine.
DB13324
The risk or severity of adverse effects can be increased when Tetrazepam is combined with Indalpine.
DB13331
The risk or severity of adverse effects can be increased when Pyrithyldione is combined with Indalpine.
DB13354
The risk or severity of adverse effects can be increased when Phenprobamate is combined with Indalpine.
DB13357
The risk or severity of adverse effects can be increased when Styramate is combined with Indalpine.
DB13362
The risk or severity of adverse effects can be increased when Pheneturide is combined with Indalpine.
DB13370
The risk or severity of adverse effects can be increased when Bromisoval is combined with Indalpine.
DB13377
The risk or severity of adverse effects can be increased when Vinbarbital is combined with Indalpine.
DB13382
The risk or severity of adverse effects can be increased when Chlorproethazine is combined with Indalpine.
DB13384
The risk or severity of adverse effects can be increased when Melitracen is combined with Indalpine.
DB13396
The risk or severity of adverse effects can be increased when Neocitrullamon is combined with Indalpine.
DB13402
The risk or severity of adverse effects can be increased when Acetylglycinamide chloral hydrate is combined with Indalpine.
DB13403
The risk or severity of adverse effects can be increased when Oxypertine is combined with Indalpine.
DB13414
The risk or severity of adverse effects can be increased when Fenyramidol is combined with Indalpine.
DB13420
The risk or severity of adverse effects can be increased when Thiazinam is combined with Indalpine.
DB13457
The risk or severity of adverse effects can be increased when Oxaflozane is combined with Indalpine.
DB13505
The risk or severity of adverse effects can be increased when Emepronium is combined with Indalpine.
DB13520
The risk or severity of adverse effects can be increased when Metergoline is combined with Indalpine.
DB13534
The risk or severity of adverse effects can be increased when Gedocarnil is combined with Indalpine.
DB13541
The risk or severity of adverse effects can be increased when Iprazochrome is combined with Indalpine.
DB13554
The risk or severity of adverse effects can be increased when Moperone is combined with Indalpine.
DB13557
The risk or severity of adverse effects can be increased when Thiopropazate is combined with Indalpine.
DB13572
The risk or severity of adverse effects can be increased when Emylcamate is combined with Indalpine.
DB13577
The risk or severity of adverse effects can be increased when Allobarbital is combined with Indalpine.
DB13584
The risk or severity of adverse effects can be increased when Gallamine is combined with Indalpine.
DB13588
The risk or severity of adverse effects can be increased when Naftidrofuryl is combined with Indalpine.
DB13598
The risk or severity of adverse effects can be increased when Diethyl ether is combined with Indalpine.
DB13623
The risk or severity of adverse effects can be increased when Fabomotizole is combined with Indalpine.
DB13642
The risk or severity of adverse effects can be increased when Pridinol is combined with Indalpine.
DB13648
The risk or severity of adverse effects can be increased when Alcuronium is combined with Indalpine.
DB13662
The risk or severity of adverse effects can be increased when Hexapropymate is combined with Indalpine.
DB13676
The risk or severity of adverse effects can be increased when Mosapramine is combined with Indalpine.
DB13687
The risk or severity of adverse effects can be increased when Niaprazine is combined with Indalpine.
DB13690
The risk or severity of adverse effects can be increased when Vinyl ether is combined with Indalpine.
DB13733
The risk or severity of adverse effects can be increased when Methylpentynol is combined with Indalpine.
DB13737
The risk or severity of adverse effects can be increased when Cyclobarbital is combined with Indalpine.
DB13745
The risk or severity of adverse effects can be increased when Fazadinium bromide is combined with Indalpine.
DB13754
The risk or severity of adverse effects can be increased when Mephenoxalone is combined with Indalpine.
DB13770
The risk or severity of adverse effects can be increased when Vinylbital is combined with Indalpine.
DB13782
The risk or severity of adverse effects can be increased when Imipramine oxide is combined with Indalpine.
DB13799
The risk or severity of adverse effects can be increased when Ethadione is combined with Indalpine.
DB13805
The risk or severity of adverse effects can be increased when Reposal is combined with Indalpine.
DB13817
The risk or severity of adverse effects can be increased when Carbromal is combined with Indalpine.
DB13837
The risk or severity of adverse effects can be increased when Doxefazepam is combined with Indalpine.
DB13872
The risk or severity of adverse effects can be increased when Lormetazepam is combined with Indalpine.
DB13940
The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylthioamphetamine is combined with Indalpine.
DB13948
The risk or severity of adverse effects can be increased when N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine is combined with Indalpine.
DB13984
The risk or severity of adverse effects can be increased when Cyclopropane is combined with Indalpine.
DB13993
The risk or severity of adverse effects can be increased when MRK-409 is combined with Indalpine.
DB14010
The risk or severity of adverse effects can be increased when 5-methoxy-N,N-dimethyltryptamine is combined with Indalpine.
DB14050
The risk or severity of adverse effects can be increased when Cannabidivarin is combined with Indalpine.
DB14575
The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Indalpine.
DB14651
The risk or severity of adverse effects can be increased when Perphenazine enanthate is combined with Indalpine.
DB14672
The risk or severity of adverse effects can be increased when Oxazepam acetate is combined with Indalpine.
DB14715
The risk or severity of adverse effects can be increased when Cinazepam is combined with Indalpine.
DB14718
The risk or severity of adverse effects can be increased when Pyrazolam is combined with Indalpine.
DB14719
The risk or severity of adverse effects can be increased when Bentazepam is combined with Indalpine.
DB14754
The risk or severity of adverse effects can be increased when Solriamfetol is combined with Indalpine.
DB15203
The risk or severity of adverse effects can be increased when JNJ-26489112 is combined with Indalpine.
DB00150
The risk or severity of adverse effects can be increased when Tryptophan is combined with Indalpine.
DB00176
The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Indalpine.
DB00186
The risk or severity of adverse effects can be increased when Lorazepam is combined with Indalpine.
DB00206
The risk or severity of adverse effects can be increased when Reserpine is combined with Indalpine.
DB00215
The risk or severity of adverse effects can be increased when Citalopram is combined with Indalpine.
DB00231
The risk or severity of adverse effects can be increased when Temazepam is combined with Indalpine.
DB00234
The risk or severity of adverse effects can be increased when Reboxetine is combined with Indalpine.
DB00285
The risk or severity of adverse effects can be increased when Venlafaxine is combined with Indalpine.
DB00313
The risk or severity of adverse effects can be increased when Valproic acid is combined with Indalpine.
DB00334
The risk or severity of adverse effects can be increased when Olanzapine is combined with Indalpine.
DB00344
The risk or severity of adverse effects can be increased when Protriptyline is combined with Indalpine.
DB00349
The risk or severity of adverse effects can be increased when Clobazam is combined with Indalpine.
DB00371
The risk or severity of adverse effects can be increased when Meprobamate is combined with Indalpine.
DB00391
The risk or severity of adverse effects can be increased when Sulpiride is combined with Indalpine.
DB00408
The risk or severity of adverse effects can be increased when Loxapine is combined with Indalpine.
DB00409
The risk or severity of adverse effects can be increased when Remoxipride is combined with Indalpine.
DB00420
The risk or severity of adverse effects can be increased when Promazine is combined with Indalpine.
DB00433
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Indalpine.
DB00475
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Indalpine.
DB00476
The risk or severity of adverse effects can be increased when Duloxetine is combined with Indalpine.
DB00477
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Indalpine.
DB00508
The risk or severity of adverse effects can be increased when Triflupromazine is combined with Indalpine.
DB00543
The risk or severity of adverse effects can be increased when Amoxapine is combined with Indalpine.
DB00546
The risk or severity of adverse effects can be increased when Adinazolam is combined with Indalpine.
DB00555
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Indalpine.
DB00623
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Indalpine.
DB00628
The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Indalpine.
DB00679
The risk or severity of adverse effects can be increased when Thioridazine is combined with Indalpine.
DB00690
The risk or severity of adverse effects can be increased when Flurazepam is combined with Indalpine.
DB00715
The risk or severity of adverse effects can be increased when Paroxetine is combined with Indalpine.
DB00726
The risk or severity of adverse effects can be increased when Trimipramine is combined with Indalpine.
DB00734
The risk or severity of adverse effects can be increased when Risperidone is combined with Indalpine.
DB00801
The risk or severity of adverse effects can be increased when Halazepam is combined with Indalpine.
DB00829
The risk or severity of adverse effects can be increased when Diazepam is combined with Indalpine.
DB00831
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Indalpine.
DB00837
The risk or severity of adverse effects can be increased when Progabide is combined with Indalpine.
DB00842
The risk or severity of adverse effects can be increased when Oxazepam is combined with Indalpine.
DB00850
The risk or severity of adverse effects can be increased when Perphenazine is combined with Indalpine.
DB00875
The risk or severity of adverse effects can be increased when Flupentixol is combined with Indalpine.
DB00904
The risk or severity of adverse effects can be increased when Ondansetron is combined with Indalpine.
DB00933
The risk or severity of adverse effects can be increased when Mesoridazine is combined with Indalpine.
DB00934
The risk or severity of adverse effects can be increased when Maprotiline is combined with Indalpine.
DB00996
The risk or severity of adverse effects can be increased when Gabapentin is combined with Indalpine.
DB01104
The risk or severity of adverse effects can be increased when Sertraline is combined with Indalpine.
DB01105
The risk or severity of adverse effects can be increased when Sibutramine is combined with Indalpine.
DB01149
The risk or severity of adverse effects can be increased when Nefazodone is combined with Indalpine.
DB01151
The risk or severity of adverse effects can be increased when Desipramine is combined with Indalpine.
DB01156
The risk or severity of adverse effects can be increased when Bupropion is combined with Indalpine.
DB01178
The risk or severity of adverse effects can be increased when Chlormezanone is combined with Indalpine.
DB01215
The risk or severity of adverse effects can be increased when Estazolam is combined with Indalpine.
DB01224
The risk or severity of adverse effects can be increased when Quetiapine is combined with Indalpine.
DB01239
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Indalpine.
DB01267
The risk or severity of adverse effects can be increased when Paliperidone is combined with Indalpine.
DB01356
The risk or severity of adverse effects can be increased when Lithium cation is combined with Indalpine.
DB01445
The risk or severity of adverse effects can be increased when Bufotenine is combined with Indalpine.
DB01454
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Indalpine.
DB01463
The risk or severity of adverse effects can be increased when Fencamfamin is combined with Indalpine.
DB01472
The risk or severity of adverse effects can be increased when 4-Methoxyamphetamine is combined with Indalpine.
DB01484
The risk or severity of adverse effects can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Indalpine.
DB01488
The risk or severity of adverse effects can be increased when Dimethyltryptamine is combined with Indalpine.
DB01509
The risk or severity of adverse effects can be increased when Tenamfetamine is combined with Indalpine.
DB01544
The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Indalpine.
DB01545
The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Indalpine.
DB01558
The risk or severity of adverse effects can be increased when Bromazepam is combined with Indalpine.
DB01560
The risk or severity of adverse effects can be increased when Cathinone is combined with Indalpine.
DB01567
The risk or severity of adverse effects can be increased when Fludiazepam is combined with Indalpine.
DB01587
The risk or severity of adverse effects can be increased when Ketazolam is combined with Indalpine.
DB01588
The risk or severity of adverse effects can be increased when Prazepam is combined with Indalpine.
DB01595
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Indalpine.
DB01614
The risk or severity of adverse effects can be increased when Acepromazine is combined with Indalpine.
DB01615
The risk or severity of adverse effects can be increased when Aceprometazine is combined with Indalpine.
DB01618
The risk or severity of adverse effects can be increased when Molindone is combined with Indalpine.
DB01623
The risk or severity of adverse effects can be increased when Thiothixene is combined with Indalpine.
DB01624
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Indalpine.
DB01954
The risk or severity of adverse effects can be increased when Rolipram is combined with Indalpine.
DB02207
The risk or severity of adverse effects can be increased when 7-Nitroindazole is combined with Indalpine.
DB02959
The risk or severity of adverse effects can be increased when Oxitriptan is combined with Indalpine.
DB03575
The risk or severity of adverse effects can be increased when Phencyclidine is combined with Indalpine.
DB04325
The risk or severity of adverse effects can be increased when Phenethylamine is combined with Indalpine.
DB04599
The risk or severity of adverse effects can be increased when Aniracetam is combined with Indalpine.
DB04829
The risk or severity of adverse effects can be increased when Lysergic acid diethylamide is combined with Indalpine.
DB04836
The risk or severity of adverse effects can be increased when Amineptine is combined with Indalpine.
DB04842
The risk or severity of adverse effects can be increased when Fluspirilene is combined with Indalpine.
DB04872
The risk or severity of adverse effects can be increased when Osanetant is combined with Indalpine.
DB04896
The risk or severity of adverse effects can be increased when Milnacipran is combined with Indalpine.
DB05316
The risk or severity of adverse effects can be increased when Pimavanserin is combined with Indalpine.
DB06016
The risk or severity of adverse effects can be increased when Cariprazine is combined with Indalpine.
DB06144
The risk or severity of adverse effects can be increased when Sertindole is combined with Indalpine.
DB06148
The risk or severity of adverse effects can be increased when Mianserin is combined with Indalpine.
DB06153
The risk or severity of adverse effects can be increased when Pizotifen is combined with Indalpine.
DB06216
The risk or severity of adverse effects can be increased when Asenapine is combined with Indalpine.
DB06288
The risk or severity of adverse effects can be increased when Amisulpride is combined with Indalpine.
DB06512
The risk or severity of adverse effects can be increased when Deramciclane is combined with Indalpine.
DB06579
The risk or severity of adverse effects can be increased when Adipiplon is combined with Indalpine.
DB06582
The risk or severity of adverse effects can be increased when Dextofisopam is combined with Indalpine.
DB06678
The risk or severity of adverse effects can be increased when Esmirtazapine is combined with Indalpine.
DB06684
The risk or severity of adverse effects can be increased when Vilazodone is combined with Indalpine.
DB06700
The risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Indalpine.
DB08811
The risk or severity of adverse effects can be increased when Tofisopam is combined with Indalpine.
DB08918
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Indalpine.
DB08922
The risk or severity of adverse effects can be increased when Perospirone is combined with Indalpine.
DB08927
The risk or severity of adverse effects can be increased when Amperozide is combined with Indalpine.
DB08986
The risk or severity of adverse effects can be increased when Indalpine is combined with Etifoxine.
DB09016
The risk or severity of adverse effects can be increased when Indalpine is combined with Butriptyline.
DB09023
The risk or severity of adverse effects can be increased when Indalpine is combined with Benactyzine.
DB09068
The risk or severity of adverse effects can be increased when Indalpine is combined with Vortioxetine.
DB09166
The risk or severity of adverse effects can be increased when Indalpine is combined with Etizolam.
DB09167
The risk or severity of adverse effects can be increased when Indalpine is combined with Dosulepin.
DB09185
The risk or severity of adverse effects can be increased when Indalpine is combined with Viloxazine.
DB09224
The risk or severity of adverse effects can be increased when Indalpine is combined with Melperone.
DB09225
The risk or severity of adverse effects can be increased when Indalpine is combined with Zotepine.
DB09226
The risk or severity of adverse effects can be increased when Indalpine is combined with Brilaroxazine.
DB09286
The risk or severity of adverse effects can be increased when Indalpine is combined with Pipamperone.
DB09307
The risk or severity of adverse effects can be increased when Indalpine is combined with Oxaprotiline.
DB11376
The risk or severity of adverse effects can be increased when Indalpine is combined with Azaperone.
DB11555
The risk or severity of adverse effects can be increased when Indalpine is combined with Zolazepam.
DB11664
The risk or severity of adverse effects can be increased when Indalpine is combined with Psilocybin.
DB12093
The risk or severity of adverse effects can be increased when Indalpine is combined with Tetrahydropalmatine.
DB12184
The risk or severity of adverse effects can be increased when Indalpine is combined with Gepirone.
DB12273
The risk or severity of adverse effects can be increased when Indalpine is combined with Ecopipam.
DB12327
The risk or severity of adverse effects can be increased when Indalpine is combined with Salvinorin A.
DB12401
The risk or severity of adverse effects can be increased when Indalpine is combined with Bromperidol.
DB12518
The risk or severity of adverse effects can be increased when Indalpine is combined with Raclopride.
DB12693
The risk or severity of adverse effects can be increased when Indalpine is combined with Ritanserin.
DB12710
The risk or severity of adverse effects can be increased when Indalpine is combined with Perazine.
DB12833
The risk or severity of adverse effects can be increased when Indalpine is combined with Tandospirone.
DB12867
The risk or severity of adverse effects can be increased when Indalpine is combined with Benperidol.
DB12930
The risk or severity of adverse effects can be increased when Indalpine is combined with Opipramol.
DB13014
The risk or severity of adverse effects can be increased when Indalpine is combined with Hypericin.
DB13025
The risk or severity of adverse effects can be increased when Indalpine is combined with Tiapride.
DB13082
The risk or severity of adverse effects can be increased when Indalpine is combined with Nefiracetam.
DB13225
The risk or severity of adverse effects can be increased when Indalpine is combined with Dibenzepin.
DB13233
The risk or severity of adverse effects can be increased when Indalpine is combined with Alaproclate.
DB13256
The risk or severity of adverse effects can be increased when Indalpine is combined with Clothiapine.
DB13273
The risk or severity of adverse effects can be increased when Indalpine is combined with Sultopride.
DB13335
The risk or severity of adverse effects can be increased when Indalpine is combined with Pinazepam.
DB13352
The risk or severity of adverse effects can be increased when Indalpine is combined with Deanol.
DB13411
The risk or severity of adverse effects can be increased when Indalpine is combined with Lofepramine.
DB13437
The risk or severity of adverse effects can be increased when Indalpine is combined with Medazepam.
DB13455
The risk or severity of adverse effects can be increased when Indalpine is combined with Phenibut.
DB13496
The risk or severity of adverse effects can be increased when Indalpine is combined with Iprindole.
DB13522
The risk or severity of adverse effects can be increased when Indalpine is combined with Mebicar.
DB13523
The risk or severity of adverse effects can be increased when Indalpine is combined with Veralipride.
DB13550
The risk or severity of adverse effects can be increased when Indalpine is combined with Bifemelane.
DB13552
The risk or severity of adverse effects can be increased when Indalpine is combined with Trifluperidol.
DB13601
The risk or severity of adverse effects can be increased when Indalpine is combined with Oxiracetam.
DB13643
The risk or severity of adverse effects can be increased when Indalpine is combined with Loprazolam.
DB13665
The risk or severity of adverse effects can be increased when Indalpine is combined with Fluanisone.
DB13784
The risk or severity of adverse effects can be increased when Indalpine is combined with Dixyrazine.
DB13791
The risk or severity of adverse effects can be increased when Indalpine is combined with Penfluridol.
DB13841
The risk or severity of adverse effects can be increased when Indalpine is combined with Clopenthixol.
DB14028
The risk or severity of adverse effects can be increased when Indalpine is combined with Nordazepam.
DB00937
The risk or severity of adverse effects can be increased when Diethylpropion is combined with Indalpine.
DB00953
The risk or severity of adverse effects can be increased when Rizatriptan is combined with Indalpine.
DB00312
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Indalpine.
DB00776
The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Indalpine.
DB00794
The risk or severity of adverse effects can be increased when Primidone is combined with Indalpine.
DB01174
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Indalpine.
DB01323
The risk or severity of adverse effects can be increased when St. John's Wort is combined with Indalpine.
DB00273
The risk or severity of adverse effects can be increased when Indalpine is combined with Topiramate.
DB00625
The risk or severity of adverse effects can be increased when Efavirenz is combined with Indalpine.
DB09118
The risk or severity of adverse effects can be increased when Stiripentol is combined with Indalpine.
DB00468
The risk or severity of adverse effects can be increased when Quinine is combined with Indalpine.
DB00252
The risk or severity of adverse effects can be increased when Phenytoin is combined with Indalpine.
DB11951
The risk or severity of adverse effects can be increased when Lemborexant is combined with Indalpine.
DB00321
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Indalpine.
DB00458
The risk or severity of adverse effects can be increased when Imipramine is combined with Indalpine.
DB01142
The risk or severity of adverse effects can be increased when Doxepin is combined with Indalpine.
DB00216
The risk or severity of adverse effects can be increased when Eletriptan is combined with Indalpine.
DB00247
The risk or severity of adverse effects can be increased when Methysergide is combined with Indalpine.
DB00593
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Indalpine.
DB00897
The risk or severity of adverse effects can be increased when Triazolam is combined with Indalpine.
DB01200
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Indalpine.
DB00751
The risk or severity of adverse effects can be increased when Epinastine is combined with Indalpine.
DB00363
The risk or severity of adverse effects can be increased when Clozapine is combined with Indalpine.
DB00604
The risk or severity of adverse effects can be increased when Cisapride is combined with Indalpine.
DB00187
The serum concentration of Esmolol can be increased when it is combined with Indalpine.
DB00195
The serum concentration of Betaxolol can be increased when it is combined with Indalpine.
DB00264
The serum concentration of Metoprolol can be increased when it is combined with Indalpine.
DB00335
The serum concentration of Atenolol can be increased when it is combined with Indalpine.
DB00373
The serum concentration of Timolol can be increased when it is combined with Indalpine.
DB00489
The serum concentration of Sotalol can be increased when it is combined with Indalpine.
DB00571
The serum concentration of Propranolol can be increased when it is combined with Indalpine.
DB00598
The serum concentration of Labetalol can be increased when it is combined with Indalpine.
DB00612
The serum concentration of Bisoprolol can be increased when it is combined with Indalpine.
DB01136
The serum concentration of Carvedilol can be increased when it is combined with Indalpine.
DB01182
The serum concentration of Propafenone can be increased when it is combined with Indalpine.
DB01193
The serum concentration of Acebutolol can be increased when it is combined with Indalpine.
DB01203
The serum concentration of Nadolol can be increased when it is combined with Indalpine.
DB01295
The serum concentration of Bevantolol can be increased when it is combined with Indalpine.
DB01297
The serum concentration of Practolol can be increased when it is combined with Indalpine.
DB03322
The serum concentration of Dexpropranolol can be increased when it is combined with Indalpine.
DB04846
The serum concentration of Celiprolol can be increased when it is combined with Indalpine.
DB04861
The serum concentration of Nebivolol can be increased when it is combined with Indalpine.
DB06726
The serum concentration of Bufuralol can be increased when it is combined with Indalpine.
DB08807
The serum concentration of Bopindolol can be increased when it is combined with Indalpine.
DB08808
The serum concentration of Bupranolol can be increased when it is combined with Indalpine.
DB08952
The serum concentration of Indenolol can be increased when it is combined with Indalpine.
DB09204
The serum concentration of Arotinolol can be increased when it is combined with Indalpine.
DB09351
The serum concentration of Levobetaxolol can be increased when it is combined with Indalpine.
DB11770
The serum concentration of Talinolol can be increased when it is combined with Indalpine.
DB11785
The serum concentration of Anisodamine can be increased when it is combined with Indalpine.
DB12752
The serum concentration of Bucindolol can be increased when it is combined with Indalpine.
DB13443
The serum concentration of Esatenolol can be increased when it is combined with Indalpine.
DB13508
The serum concentration of Cloranolol can be increased when it is combined with Indalpine.
DB13530
The serum concentration of Mepindolol can be increased when it is combined with Indalpine.
DB13757
The serum concentration of Epanolol can be increased when it is combined with Indalpine.
DB13775
The serum concentration of Tertatolol can be increased when it is combined with Indalpine.
DB12212
The serum concentration of Landiolol can be increased when it is combined with Indalpine.
DB00017
The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Indalpine.
DB00024
The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Indalpine.
DB00066
The therapeutic efficacy of Follitropin can be decreased when used in combination with Indalpine.
DB00279
The therapeutic efficacy of Liothyronine can be decreased when used in combination with Indalpine.
DB00389
The therapeutic efficacy of Carbimazole can be decreased when used in combination with Indalpine.
DB00550
The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Indalpine.
DB03374
The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Indalpine.
DB03604
The therapeutic efficacy of Tiratricol can be decreased when used in combination with Indalpine.
DB05084
The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Indalpine.
DB05829
The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Indalpine.
DB06285
The therapeutic efficacy of Teriparatide can be decreased when used in combination with Indalpine.
DB06715
The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Indalpine.
DB07637
The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Indalpine.
DB09100
The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Indalpine.
DB09418
The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Indalpine.
DB09421
The therapeutic efficacy of Protirelin can be decreased when used in combination with Indalpine.
DB13644
The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Indalpine.
DB13742
The therapeutic efficacy of Elcatonin can be decreased when used in combination with Indalpine.
DB13804
The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Indalpine.
DB15263
The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Indalpine.
DB00763
The therapeutic efficacy of Methimazole can be decreased when used in combination with Indalpine.
DB01583
The therapeutic efficacy of Liotrix can be decreased when used in combination with Indalpine.
DB12629
The therapeutic efficacy of 3,5-diiodothyropropionic acid can be decreased when used in combination with Indalpine.
DB00451
The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Indalpine.
DB09241
Indalpine may increase the serotonergic activities of Methylene blue.
DB00159
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Icosapent.
DB00244
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Mesalazine.
DB00328
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Indomethacin.
DB00461
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Nabumetone.
DB00465
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Ketorolac.
DB00469
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Tenoxicam.
DB00500
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Tolmetin.
DB00554
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Piroxicam.
DB00573
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Fenoprofen.
DB00605
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Sulindac.
DB00712
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Flurbiprofen.
DB00749
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Etodolac.
DB00784
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Mefenamic acid.
DB00788
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Naproxen.
DB00795
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Sulfasalazine.
DB00821
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Carprofen.
DB00861
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Diflunisal.
DB00936
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Salicylic acid.
DB00939
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Meclofenamic acid.
DB00991
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Oxaprozin.
DB01009
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Ketoprofen.
DB01014
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Balsalazide.
DB01050
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Ibuprofen.
DB01250
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Olsalazine.
DB01283
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Lumiracoxib.
DB01397
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Magnesium salicylate.
DB01399
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Salsalate.
DB01401
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Choline magnesium trisalicylate.
DB01419
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Antrafenine.
DB01600
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Tiaprofenic acid.
DB02224
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Taxifolin.
DB03585
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Oxyphenbutazone.
DB04725
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Licofelone.
DB04812
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Benoxaprofen.
DB05095
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Cimicoxib.
DB06725
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Lornoxicam.
DB06736
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Aceclofenac.
DB06737
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Zaltoprofen.
DB07402
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Azapropazone.
DB08797
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Salicylamide.
DB08940
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Kebuzone.
DB08942
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Isoxicam.
DB08951
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Indoprofen.
DB08955
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Ibuproxam.
DB08976
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Floctafenine.
DB08981
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Fenbufen.
DB08984
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Etofenamate.
DB08991
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Epirizole.
DB09084
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Benzydamine.
DB09213
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Dexibuprofen.
DB09214
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Dexketoprofen.
DB09215
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Droxicam.
DB09217
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Firocoxib.
DB09218
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Clonixin.
DB09285
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Morniflumate.
DB09295
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Talniflumate.
DB11455
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Robenacoxib.
DB11466
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Tepoxalin.
DB11518
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Flunixin.
DB12399
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Polmacoxib.
DB12610
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Ebselen.
DB13001
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Tinoridine.
DB13167
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Alclofenac.
DB13217
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Fentiazac.
DB13232
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Suxibuzone.
DB13286
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Bumadizone.
DB13314
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Alminoprofen.
DB13371
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Difenpiramide.
DB13407
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Nifenazone.
DB13432
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Lonazolac.
DB13481
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Tenidap.
DB13524
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Propyphenazone.
DB13527
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Proglumetacin.
DB13538
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Guacetisal.
DB13544
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Ethenzamide.
DB13612
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Carbaspirin calcium.
DB13629
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Mofebutazone.
DB13649
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Proquazone.
DB13657
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Benorilate.
DB13722
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Pirprofen.
DB13783
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Acemetacin.
DB13860
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Imidazole salicylate.
DB14059
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with SC-236.
DB14060
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with NS-398.
DB14938
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Flurbiprofen axetil.
DB04743
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Nimesulide.
DB12445
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Nitroaspirin.
DB12545
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Indobufen.
DB00580
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Valdecoxib.
DB00586
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Diclofenac.
DB00814
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Meloxicam.
DB01424
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Aminophenazone.
DB01435
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Antipyrine.
DB01628
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Etoricoxib.
DB04828
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Zomepirac.
DB08439
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Parecoxib.
DB09216
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Tolfenamic acid.
DB00533
The risk or severity of gastrointestinal bleeding can be increased when Rofecoxib is combined with Indalpine.
DB00812
The risk or severity of gastrointestinal bleeding can be increased when Phenylbutazone is combined with Indalpine.
DB04817
The risk or severity of gastrointestinal bleeding can be increased when Metamizole is combined with Indalpine.
DB09288
The risk or severity of gastrointestinal bleeding can be increased when Propacetamol is combined with Indalpine.
DB09212
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Loxoprofen.
DB00182
Amphetamine may increase the serotonergic activities of Indalpine.
DB00614
Furazolidone may increase the serotonergic activities of Indalpine.
DB00721
Procaine may increase the serotonergic activities of Indalpine.
DB01168
Procarbazine may increase the serotonergic activities of Indalpine.
DB01367
Rasagiline may increase the serotonergic activities of Indalpine.
DB01626
Pargyline may increase the serotonergic activities of Indalpine.
DB06654
Safinamide may increase the serotonergic activities of Indalpine.
DB08550
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the serotonergic activities of Indalpine.
DB09243
Hydracarbazine may increase the serotonergic activities of Indalpine.
DB09246
Benmoxin may increase the serotonergic activities of Indalpine.
DB09248
Mebanazine may increase the serotonergic activities of Indalpine.
DB09249
Octamoxin may increase the serotonergic activities of Indalpine.
DB09250
Pheniprazine may increase the serotonergic activities of Indalpine.
DB09251
Phenoxypropazine may increase the serotonergic activities of Indalpine.
DB09252
Pivhydrazine may increase the serotonergic activities of Indalpine.
DB09253
Safrazine may increase the serotonergic activities of Indalpine.
DB09254
Caroxazone may increase the serotonergic activities of Indalpine.
DB13875
Harmaline may increase the serotonergic activities of Indalpine.
DB13876
Brofaromine may increase the serotonergic activities of Indalpine.
DB00752
Tranylcypromine may increase the serotonergic activities of Indalpine.
DB00780
Phenelzine may increase the serotonergic activities of Indalpine.
DB00805
Minaprine may increase the serotonergic activities of Indalpine.
DB01037
Selegiline may increase the serotonergic activities of Indalpine.
DB01171
Moclobemide may increase the serotonergic activities of Indalpine.
DB01247
Isocarboxazid may increase the serotonergic activities of Indalpine.
DB04017
Clorgiline may increase the serotonergic activities of Indalpine.
DB04818
Iproniazid may increase the serotonergic activities of Indalpine.
DB04820
Nialamide may increase the serotonergic activities of Indalpine.
DB09244
Indalpine may increase the serotonergic activities of Pirlindole.
DB09245
Indalpine may increase the serotonergic activities of Toloxatone.
DB00209
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Trospium.
DB00219
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00245
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00332
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.
DB00340
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Metixene.
DB00354
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Buclizine.
DB00376
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
DB00383
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.
DB00387
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.
DB00392
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Profenamine.
DB00424
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
DB00462
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine bromide.
DB00505
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.
DB00517
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Anisotropine methylbromide.
DB00572
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Atropine.
DB00670
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.
DB00725
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.
DB00767
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Benzquinamide.
DB00782
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
DB00804
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
DB00810
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Biperiden.
DB00940
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Methantheline.
DB00942
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Cycrimine.
DB00986
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
DB01148
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
DB01231
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Diphenidol.
DB01625
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.
DB04843
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.
DB06787
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.
DB08801
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.
DB08897
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Aclidinium.
DB08997
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.
DB09076
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Umeclidinium.
DB09300
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.
DB11235
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.
DB11315
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.
DB11855
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.
DB12086
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Oxitropium.
DB12526
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Batefenterol.
DB12554
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.
DB13252
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.
DB13254
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Prifinium.
DB13351
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.
DB13369
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Benzilone.
DB13380
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Difemerine.
DB13413
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Phenglutarimide.
DB13448
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Mazaticol.
DB13468
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Etybenzatropine.
DB13507
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Poldine.
DB13542
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Bevonium.
DB13581
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Rociverine.
DB13619
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.
DB13636
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Etanautine.
DB13666
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Tiemonium iodide.
DB13678
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.
DB13695
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Penthienate.
DB13720
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.
DB13738
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Camylofin.
DB13759
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Fenpiverinium.
DB13769
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Emetonium iodide.
DB13844
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.
DB13850
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Timepidium.
DB00622
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Nicardipine.
DB01036
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.
DB01062
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
DB01409
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Tiotropium.
DB01591
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
DB06702
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
DB09089
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.
DB09262
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Imidafenacin.
DB12278
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Propiverine.
DB13500
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Otilonium.
DB00496
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
DB00342
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Terfenadine.
DB09007
Indalpine may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.
DB00071
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Insulin pork.
DB00331
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Metformin.
DB00414
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Acetohexamide.
DB00914
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Phenformin.
DB01251
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Gliquidone.
DB01252
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Mitiglinide.
DB01289
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Glisoxepide.
DB01382
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Glymidine.
DB01700
The risk or severity of hypoglycemia can be increased when Indalpine is combined with AICA ribonucleotide.
DB04830
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Buformin.
DB04876
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Vildagliptin.
DB04878
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Voglibose.
DB05115
The risk or severity of hypoglycemia can be increased when Indalpine is combined with NN344.
DB05819
The risk or severity of hypoglycemia can be increased when Indalpine is combined with NBI-6024.
DB06011
The risk or severity of hypoglycemia can be increased when Indalpine is combined with AMG-222.
DB06127
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Bisegliptin.
DB08382
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Gosogliptin.
DB08962
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Glibornuride.
DB09022
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Benfluorex.
DB09038
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Empagliflozin.
DB09043
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Albiglutide.
DB09045
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Dulaglutide.
DB09265
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Lixisenatide.
DB09456
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Insulin beef.
DB09564
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Insulin degludec.
DB11567
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Insulin peglispro.
DB11568
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Insulin tregopil.
DB11698
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Ipragliflozin.
DB11723
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Dutogliptin.
DB11780
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Allicin.
DB11824
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Tofogliflozin.
DB11827
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Ertugliflozin.
DB11898
The risk or severity of hypoglycemia can be increased when Indalpine is combined with 2,4-thiazolidinedione.
DB11950
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Teneligliptin.
DB11992
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Omarigliptin.
DB12268
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Carmegliptin.
DB12412
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Gemigliptin.
DB12417
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Anagliptin.
DB12625
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Evogliptin.
DB12713
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Sotagliflozin.
DB12935
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Remogliflozin etabonate.
DB13406
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Carbutamide.
DB13446
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Guar gum.
DB13675
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Metahexamide.
DB13928
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Semaglutide.
DB14027
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Taspoglutide.
DB14035
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Englitazone.
DB15171
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Tirzepatide.
DB15217
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Gastric inhibitory polypeptide.
DB00030
The risk or severity of hypoglycemia can be increased when Insulin human is combined with Indalpine.
DB00046
The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Indalpine.
DB00047
The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Indalpine.
DB00222
The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Indalpine.
DB00263
The risk or severity of hypoglycemia can be increased when Sulfisoxazole is combined with Indalpine.
DB00284
The risk or severity of hypoglycemia can be increased when Acarbose is combined with Indalpine.
DB00491
The risk or severity of hypoglycemia can be increased when Miglitol is combined with Indalpine.
DB00672
The risk or severity of hypoglycemia can be increased when Chlorpropamide is combined with Indalpine.
DB00738
The risk or severity of hypoglycemia can be increased when Pentamidine is combined with Indalpine.
DB00839
The risk or severity of hypoglycemia can be increased when Tolazamide is combined with Indalpine.
DB01120
The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Indalpine.
DB01124
The risk or severity of hypoglycemia can be increased when Tolbutamide is combined with Indalpine.
DB01276
The risk or severity of hypoglycemia can be increased when Exenatide is combined with Indalpine.
DB01277
The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Indalpine.
DB01278
The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Indalpine.
DB01306
The risk or severity of hypoglycemia can be increased when Insulin aspart is combined with Indalpine.
DB01307
The risk or severity of hypoglycemia can be increased when Insulin detemir is combined with Indalpine.
DB01309
The risk or severity of hypoglycemia can be increased when Insulin glulisine is combined with Indalpine.
DB06655
The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Indalpine.
DB00280
The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Indalpine.
DB00359
The risk or severity of hypoglycemia can be increased when Sulfadiazine is combined with Indalpine.
DB00412
The risk or severity of hypoglycemia can be increased when Rosiglitazone is combined with Indalpine.
DB00731
The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Indalpine.
DB00834
The risk or severity of hypoglycemia can be increased when Mifepristone is combined with Indalpine.
DB00912
The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Indalpine.
DB01015
The risk or severity of hypoglycemia can be increased when Sulfamethoxazole is combined with Indalpine.
DB01016
The risk or severity of hypoglycemia can be increased when Glyburide is combined with Indalpine.
DB01067
The risk or severity of hypoglycemia can be increased when Glipizide is combined with Indalpine.
DB01132
The risk or severity of hypoglycemia can be increased when Pioglitazone is combined with Indalpine.
DB01261
The risk or severity of hypoglycemia can be increased when Sitagliptin is combined with Indalpine.
DB06335
The risk or severity of hypoglycemia can be increased when Saxagliptin is combined with Indalpine.
DB00197
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Troglitazone.
DB06203
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Alogliptin.
DB06292
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Dapagliflozin.
DB08907
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Canagliflozin.
DB09198
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Lobeglitazone.
DB09199
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Netoglitazone.
DB09200
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Rivoglitazone.
DB09201
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Ciglitazone.
DB12781
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Balaglitazone.
DB00104
The risk or severity of hypoglycemia can be increased when Octreotide is combined with Indalpine.
DB00166
The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Indalpine.
DB01044
The risk or severity of hypoglycemia can be increased when Gatifloxacin is combined with Indalpine.
DB06663
The risk or severity of hypoglycemia can be increased when Pasireotide is combined with Indalpine.
DB06791
The risk or severity of hypoglycemia can be increased when Lanreotide is combined with Indalpine.
DB09270
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Ubidecarenone.
DB13358
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Cibenzoline.
DB14025
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Clinafloxacin.
DB00082
The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Indalpine.
DB08882
The metabolism of Indalpine can be decreased when combined with Linagliptin.
DB00207
The metabolism of Azithromycin can be decreased when combined with Indalpine.
DB00426
The metabolism of Famciclovir can be decreased when combined with Indalpine.
DB00518
The metabolism of Albendazole can be decreased when combined with Indalpine.
DB00567
The metabolism of Cephalexin can be decreased when combined with Indalpine.
DB00590
The metabolism of Doxazosin can be decreased when combined with Indalpine.
DB00717
The metabolism of Norethisterone can be decreased when combined with Indalpine.
DB01039
The metabolism of Fenofibrate can be decreased when combined with Indalpine.
DB01098
The metabolism of Rosuvastatin can be decreased when combined with Indalpine.
DB01411
The metabolism of Pranlukast can be decreased when combined with Indalpine.
DB01431
The metabolism of Allylestrenol can be decreased when combined with Indalpine.
DB01656
The metabolism of Roflumilast can be decreased when combined with Indalpine.
DB09048
The metabolism of Netupitant can be decreased when combined with Indalpine.
DB09079
The metabolism of Nintedanib can be decreased when combined with Indalpine.
DB09299
The metabolism of Tenofovir alafenamide can be decreased when combined with Indalpine.
DB11094
The metabolism of Vitamin D can be decreased when combined with Indalpine.
DB11273
The metabolism of Dihydroergocornine can be decreased when combined with Indalpine.
DB11952
The metabolism of Duvelisib can be decreased when combined with Indalpine.
DB12515
The metabolism of 9-aminocamptothecin can be decreased when combined with Indalpine.
DB12952
The metabolism of Methylprednisone can be decreased when combined with Indalpine.
DB13345
The metabolism of Dihydroergocristine can be decreased when combined with Indalpine.
DB13385
The metabolism of Dihydroergocryptine can be decreased when combined with Indalpine.
DB14009
The metabolism of Medical Cannabis can be decreased when combined with Indalpine.
DB14126
The metabolism of Tenofovir can be decreased when combined with Indalpine.
DB01072
The metabolism of Indalpine can be decreased when combined with Atazanavir.
DB11730
The metabolism of Indalpine can be decreased when combined with Ribociclib.
DB01395
The metabolism of Indalpine can be decreased when combined with Drospirenone.
DB00549
The metabolism of Indalpine can be decreased when combined with Zafirlukast.
DB12887
The metabolism of Tazemetostat can be decreased when combined with Indalpine.
DB06717
The metabolism of Fosaprepitant can be decreased when combined with Indalpine.
DB11742
The metabolism of Ebastine can be decreased when combined with Indalpine.
DB11633
The metabolism of Isavuconazole can be decreased when combined with Indalpine.
DB09195
The risk or severity of adverse effects can be increased when Indalpine is combined with Lorpiprazole.
DB05239
The metabolism of Cobimetinib can be decreased when combined with Indalpine.
DB00230
The therapeutic efficacy of Indalpine can be increased when used in combination with Pregabalin.
DB11642
The serum concentration of Indalpine can be decreased when it is combined with Pitolisant.
DB04948
The therapeutic efficacy of Indalpine can be increased when used in combination with Lofexidine.
DB00063
The risk or severity of hemorrhage can be increased when Indalpine is combined with Eptifibatide.
DB00208
The risk or severity of hemorrhage can be increased when Indalpine is combined with Ticlopidine.
DB00758
The risk or severity of hemorrhage can be increased when Indalpine is combined with Clopidogrel.
DB00775
The risk or severity of hemorrhage can be increased when Indalpine is combined with Tirofiban.
DB00806
The risk or severity of hemorrhage can be increased when Indalpine is combined with Pentoxifylline.
DB01138
The risk or severity of hemorrhage can be increased when Indalpine is combined with Sulfinpyrazone.
DB01207
The risk or severity of hemorrhage can be increased when Indalpine is combined with Ridogrel.
DB02709
The risk or severity of hemorrhage can be increased when Indalpine is combined with Resveratrol.
DB04905
The risk or severity of hemorrhage can be increased when Indalpine is combined with Tesmilifene.
DB05266
The risk or severity of hemorrhage can be increased when Indalpine is combined with Ibudilast.
DB05767
The risk or severity of hemorrhage can be increased when Indalpine is combined with Andrographolide.
DB06081
The risk or severity of hemorrhage can be increased when Indalpine is combined with Caplacizumab.
DB07615
The risk or severity of hemorrhage can be increased when Indalpine is combined with Tranilast.
DB08887
The risk or severity of hemorrhage can be increased when Indalpine is combined with Icosapent ethyl.
DB09283
The risk or severity of hemorrhage can be increased when Indalpine is combined with Trapidil.
DB12092
The risk or severity of hemorrhage can be increased when Indalpine is combined with Naftopidil.
DB12321
The risk or severity of hemorrhage can be increased when Indalpine is combined with Ifetroban.
DB12749
The risk or severity of hemorrhage can be increased when Indalpine is combined with Butylphthalide.
DB12771
The risk or severity of hemorrhage can be increased when Indalpine is combined with Hydroxytyrosol.
DB13036
The risk or severity of hemorrhage can be increased when Indalpine is combined with Ramatroban.
DB13327
The risk or severity of hemorrhage can be increased when Indalpine is combined with Picotamide.
DB13367
The risk or severity of hemorrhage can be increased when Indalpine is combined with Cloricromen.
DB13400
The risk or severity of hemorrhage can be increased when Indalpine is combined with Linsidomine.
DB13510
The risk or severity of hemorrhage can be increased when Indalpine is combined with Buflomedil.
DB13929
The risk or severity of hemorrhage can be increased when Indalpine is combined with Relcovaptan.
DB00261
The risk or severity of hemorrhage can be increased when Indalpine is combined with Anagrelide.
DB09030
The risk or severity of hemorrhage can be increased when Indalpine is combined with Vorapaxar.
DB00001
The risk or severity of hemorrhage can be increased when Indalpine is combined with Lepirudin.
DB00006
The risk or severity of hemorrhage can be increased when Indalpine is combined with Bivalirudin.
DB00009
The risk or severity of hemorrhage can be increased when Indalpine is combined with Alteplase.
DB00013
The risk or severity of hemorrhage can be increased when Indalpine is combined with Urokinase.
DB00015
The risk or severity of hemorrhage can be increased when Indalpine is combined with Reteplase.
DB00029
The risk or severity of hemorrhage can be increased when Indalpine is combined with Anistreplase.
DB00031
The risk or severity of hemorrhage can be increased when Indalpine is combined with Tenecteplase.
DB00054
The risk or severity of hemorrhage can be increased when Indalpine is combined with Abciximab.
DB00055
The risk or severity of hemorrhage can be increased when Indalpine is combined with Drotrecogin alfa.
DB00086
The risk or severity of hemorrhage can be increased when Indalpine is combined with Streptokinase.
DB00266
The risk or severity of hemorrhage can be increased when Indalpine is combined with Dicoumarol.
DB00407
The risk or severity of hemorrhage can be increased when Indalpine is combined with Ardeparin.
DB00498
The risk or severity of hemorrhage can be increased when Indalpine is combined with Phenindione.
DB00569
The risk or severity of hemorrhage can be increased when Indalpine is combined with Fondaparinux.
DB00686
The risk or severity of hemorrhage can be increased when Indalpine is combined with Pentosan polysulfate.
DB00975
The risk or severity of hemorrhage can be increased when Indalpine is combined with Dipyridamole.
DB01088
The risk or severity of hemorrhage can be increased when Indalpine is combined with Iloprost.
DB01109
The risk or severity of hemorrhage can be increased when Indalpine is combined with Heparin.
DB01225
The risk or severity of hemorrhage can be increased when Indalpine is combined with Enoxaparin.
DB01240
The risk or severity of hemorrhage can be increased when Indalpine is combined with Epoprostenol.
DB04665
The risk or severity of hemorrhage can be increased when Indalpine is combined with Coumarin.
DB04898
The risk or severity of hemorrhage can be increased when Indalpine is combined with Ximelagatran.
DB04925
The risk or severity of hemorrhage can be increased when Indalpine is combined with Desmoteplase.
DB04932
The risk or severity of hemorrhage can be increased when Indalpine is combined with Defibrotide.
DB05099
The risk or severity of hemorrhage can be increased when Indalpine is combined with Ancrod.
DB05229
The risk or severity of hemorrhage can be increased when Indalpine is combined with Beraprost.
DB05254
The risk or severity of hemorrhage can be increased when Indalpine is combined with Fibrinolysin.
DB06209
The risk or severity of hemorrhage can be increased when Indalpine is combined with Prasugrel.
DB06271
The risk or severity of hemorrhage can be increased when Indalpine is combined with Sulodexide.
DB06294
The risk or severity of hemorrhage can be increased when Indalpine is combined with Semuloparin.
DB06406
The risk or severity of hemorrhage can be increased when Indalpine is combined with Idraparinux.
DB06441
The risk or severity of hemorrhage can be increased when Indalpine is combined with Cangrelor.
DB06543
The risk or severity of hemorrhage can be increased when Indalpine is combined with Astaxanthin.
DB06605
The risk or severity of hemorrhage can be increased when Indalpine is combined with Apixaban.
DB06635
The risk or severity of hemorrhage can be increased when Indalpine is combined with Otamixaban.
DB06679
The risk or severity of hemorrhage can be increased when Indalpine is combined with Amediplase.
DB06695
The risk or severity of hemorrhage can be increased when Indalpine is combined with Dabigatran etexilate.
DB06754
The risk or severity of hemorrhage can be increased when Indalpine is combined with Danaparoid.
DB06779
The risk or severity of hemorrhage can be increased when Indalpine is combined with Dalteparin.
DB06822
The risk or severity of hemorrhage can be increased when Indalpine is combined with Tinzaparin.
DB07767
The risk or severity of hemorrhage can be increased when Indalpine is combined with Ferulic acid.
DB08813
The risk or severity of hemorrhage can be increased when Indalpine is combined with Nadroparin.
DB08814
The risk or severity of hemorrhage can be increased when Indalpine is combined with Triflusal.
DB08994
The risk or severity of hemorrhage can be increased when Indalpine is combined with Ditazole.
DB09075
The risk or severity of hemorrhage can be increased when Indalpine is combined with Edoxaban.
DB09125
The risk or severity of hemorrhage can be increased when Indalpine is combined with Potassium citrate.
DB09154
The risk or severity of hemorrhage can be increased when Indalpine is combined with Sodium citrate.
DB09255
The risk or severity of hemorrhage can be increased when Indalpine is combined with Dextran.
DB09258
The risk or severity of hemorrhage can be increased when Indalpine is combined with Bemiparin.
DB09260
The risk or severity of hemorrhage can be increased when Indalpine is combined with Parnaparin.
DB11095
The risk or severity of hemorrhage can be increased when Indalpine is combined with Desirudin.
DB11154
The risk or severity of hemorrhage can be increased when Indalpine is combined with Zinc citrate.
DB11166
The risk or severity of hemorrhage can be increased when Indalpine is combined with Antithrombin Alfa.
DB11312
The risk or severity of hemorrhage can be increased when Indalpine is combined with Protein C.
DB11598
The risk or severity of hemorrhage can be increased when Indalpine is combined with Antithrombin III human.
DB11984
The risk or severity of hemorrhage can be increased when Indalpine is combined with Letaxaban.
DB12289
The risk or severity of hemorrhage can be increased when Indalpine is combined with Darexaban.
DB12364
The risk or severity of hemorrhage can be increased when Indalpine is combined with Betrixaban.
DB12598
The risk or severity of hemorrhage can be increased when Indalpine is combined with Nafamostat.
DB12726
The risk or severity of hemorrhage can be increased when Indalpine is combined with Monteplase.
DB12831
The risk or severity of hemorrhage can be increased when Indalpine is combined with Gabexate.
DB13149
The risk or severity of hemorrhage can be increased when Indalpine is combined with Protein S human.
DB13199
The risk or severity of hemorrhage can be increased when Indalpine is combined with Brinase.
DB13451
The risk or severity of hemorrhage can be increased when Indalpine is combined with Tioclomarol.
DB13616
The risk or severity of hemorrhage can be increased when Indalpine is combined with Melagatran.
DB13646
The risk or severity of hemorrhage can be increased when Indalpine is combined with Saruplase.
DB14094
The risk or severity of hemorrhage can be increased when Indalpine is combined with Tocopherylquinone.
DB14598
The risk or severity of hemorrhage can be increased when Indalpine is combined with Edetate calcium disodium anhydrous.
DB14726
The risk or severity of hemorrhage can be increased when Indalpine is combined with Dabigatran.
DB00946
The risk or severity of hemorrhage can be increased when Indalpine is combined with Phenprocoumon.
DB03410
The risk or severity of hemorrhage can be increased when Indalpine is combined with 4-hydroxycoumarin.
DB06228
The risk or severity of hemorrhage can be increased when Indalpine is combined with Rivaroxaban.
DB08794
The risk or severity of hemorrhage can be increased when Indalpine is combined with Ethyl biscoumacetate.
DB08816
The risk or severity of hemorrhage can be increased when Indalpine is combined with Ticagrelor.
DB13136
The risk or severity of hemorrhage can be increased when Indalpine is combined with Fluindione.
DB13275
The risk or severity of hemorrhage can be increased when Indalpine is combined with Clorindione.
DB13347
The risk or severity of hemorrhage can be increased when Indalpine is combined with Diphenadione.
DB00278
The risk or severity of hemorrhage can be increased when Indalpine is combined with Argatroban.
DB13124
The risk or severity of hemorrhage can be increased when Indalpine is combined with Troxerutin.
DB00974
The risk or severity of hemorrhage can be increased when Indalpine is combined with Edetic acid.
DB09259
The risk or severity of hemorrhage can be increased when Indalpine is combined with Reviparin.
DB01238
The metabolism of Aripiprazole can be decreased when combined with Indalpine.
DB14185
The metabolism of Aripiprazole lauroxil can be decreased when combined with Indalpine.
DB09046
The metabolism of Indalpine can be increased when combined with Metreleptin.
DB11712
The metabolism of Tezacaftor can be decreased when combined with Indalpine.
DB08910
The metabolism of Indalpine can be decreased when combined with Pomalidomide.
DB00564
The metabolism of Indalpine can be decreased when combined with Carbamazepine.
DB09289
The metabolism of Tianeptine can be decreased when combined with Indalpine.
DB00248
The metabolism of Indalpine can be decreased when combined with Cabergoline.
DB09063
The metabolism of Ceritinib can be decreased when combined with Indalpine.
DB11963
The metabolism of Dacomitinib can be decreased when combined with Indalpine.
DB12015
The metabolism of Alpelisib can be decreased when combined with Indalpine.
DB09054
The metabolism of Indalpine can be decreased when combined with Idelalisib.
DB09330
The metabolism of Indalpine can be decreased when combined with Osimertinib.
DB01118
The metabolism of Amiodarone can be decreased when combined with Indalpine.
DB01320
The metabolism of Fosphenytoin can be decreased when combined with Indalpine.
DB01268
The metabolism of Indalpine can be decreased when combined with Sunitinib.
DB00091
The metabolism of Cyclosporine can be decreased when combined with Indalpine.
DB00204
The metabolism of Dofetilide can be decreased when combined with Indalpine.
DB00277
The metabolism of Theophylline can be decreased when combined with Indalpine.
DB00877
The metabolism of Sirolimus can be decreased when combined with Indalpine.
DB00908
The metabolism of Quinidine can be decreased when combined with Indalpine.
DB01008
The metabolism of Busulfan can be decreased when combined with Indalpine.
DB01223
The metabolism of Aminophylline can be decreased when combined with Indalpine.
DB01229
The metabolism of Paclitaxel can be decreased when combined with Indalpine.
DB01254
The metabolism of Dasatinib can be decreased when combined with Indalpine.
DB01396
The metabolism of Digitoxin can be decreased when combined with Indalpine.
DB04855
The metabolism of Dronedarone can be decreased when combined with Indalpine.
DB06287
The metabolism of Temsirolimus can be decreased when combined with Indalpine.
DB00320
The metabolism of Indalpine can be decreased when combined with Dihydroergotamine.
DB00540
The metabolism of Indalpine can be decreased when combined with Nortriptyline.
DB00696
The metabolism of Indalpine can be decreased when combined with Ergotamine.
DB01242
The metabolism of Indalpine can be decreased when combined with Clomipramine.
DB00637
The metabolism of Astemizole can be decreased when combined with Indalpine.
DB08827
The metabolism of Lomitapide can be decreased when combined with Indalpine.
DB00563
The metabolism of Methotrexate can be decreased when combined with Indalpine.
DB00361
The metabolism of Vinorelbine can be decreased when combined with Indalpine.
DB00541
The metabolism of Vincristine can be decreased when combined with Indalpine.
DB00570
The metabolism of Vinblastine can be decreased when combined with Indalpine.
DB00997
The metabolism of Doxorubicin can be decreased when combined with Indalpine.
DB01248
The metabolism of Docetaxel can be decreased when combined with Indalpine.
DB04572
The metabolism of Thiotepa can be decreased when combined with Indalpine.
DB05109
The metabolism of Trabectedin can be decreased when combined with Indalpine.
DB05294
The metabolism of Vandetanib can be decreased when combined with Indalpine.
DB08881
The metabolism of Vemurafenib can be decreased when combined with Indalpine.
DB11363
The metabolism of Alectinib can be decreased when combined with Indalpine.
DB11581
The metabolism of Venetoclax can be decreased when combined with Indalpine.
DB11641
The metabolism of Vinflunine can be decreased when combined with Indalpine.
DB11703
The metabolism of Acalabrutinib can be decreased when combined with Indalpine.
DB13874
The metabolism of Enasidenib can be decreased when combined with Indalpine.
DB00188
The metabolism of Bortezomib can be decreased when combined with Indalpine.
DB00309
The metabolism of Vindesine can be decreased when combined with Indalpine.
DB00398
The metabolism of Sorafenib can be decreased when combined with Indalpine.
DB00444
The metabolism of Teniposide can be decreased when combined with Indalpine.
DB00530
The metabolism of Erlotinib can be decreased when combined with Indalpine.
DB00675
The metabolism of Tamoxifen can be decreased when combined with Indalpine.
DB00773
The metabolism of Etoposide can be decreased when combined with Indalpine.
DB01181
The metabolism of Ifosfamide can be decreased when combined with Indalpine.
DB04845
The metabolism of Ixabepilone can be decreased when combined with Indalpine.
DB04868
The metabolism of Nilotinib can be decreased when combined with Indalpine.
DB06589
The metabolism of Pazopanib can be decreased when combined with Indalpine.
DB06595
The metabolism of Midostaurin can be decreased when combined with Indalpine.
DB06603
The metabolism of Panobinostat can be decreased when combined with Indalpine.
DB06616
The metabolism of Bosutinib can be decreased when combined with Indalpine.
DB06626
The metabolism of Axitinib can be decreased when combined with Indalpine.
DB08865
The metabolism of Crizotinib can be decreased when combined with Indalpine.
DB08870
The metabolism of Brentuximab vedotin can be decreased when combined with Indalpine.
DB08877
The metabolism of Ruxolitinib can be decreased when combined with Indalpine.
DB08901
The metabolism of Ponatinib can be decreased when combined with Indalpine.
DB08912
The metabolism of Dabrafenib can be decreased when combined with Indalpine.
DB09073
The metabolism of Palbociclib can be decreased when combined with Indalpine.
DB09570
The metabolism of Ixazomib can be decreased when combined with Indalpine.
DB11828
The metabolism of Neratinib can be decreased when combined with Indalpine.
DB12147
The metabolism of Erdafitinib can be decreased when combined with Indalpine.
DB12267
The metabolism of Brigatinib can be decreased when combined with Indalpine.
DB12483
The metabolism of Copanlisib can be decreased when combined with Indalpine.
DB12978
The metabolism of Pexidartinib can be decreased when combined with Indalpine.
DB14568
The metabolism of Ivosidenib can be decreased when combined with Indalpine.
DB00762
The metabolism of Irinotecan can be decreased when combined with Indalpine.
DB06176
The metabolism of Romidepsin can be decreased when combined with Indalpine.
DB06212
The metabolism of Tolvaptan can be decreased when combined with Indalpine.
DB08896
The metabolism of Regorafenib can be decreased when combined with Indalpine.
DB11817
The metabolism of Baricitinib can be decreased when combined with Indalpine.
DB12001
The metabolism of Abemaciclib can be decreased when combined with Indalpine.
DB00531
The metabolism of Cyclophosphamide can be decreased when combined with Indalpine.
DB00872
The metabolism of Conivaptan can be decreased when combined with Indalpine.
DB01128
The metabolism of Bicalutamide can be decreased when combined with Indalpine.
DB05773
The metabolism of Trastuzumab emtansine can be decreased when combined with Indalpine.
DB06772
The metabolism of Cabazitaxel can be decreased when combined with Indalpine.
DB05077
The risk or severity of adverse effects can be increased when SLV319 is combined with Indalpine.
DB06155
The risk or severity of adverse effects can be increased when Rimonabant is combined with Indalpine.
DB06624
The risk or severity of adverse effects can be increased when Taranabant is combined with Indalpine.
DB09061
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Indalpine.
DB11903
The risk or severity of adverse effects can be increased when GW842166 is combined with Indalpine.
DB12193
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Indalpine.
DB12649
The risk or severity of adverse effects can be increased when Ibipinabant is combined with Indalpine.
DB13070
The risk or severity of adverse effects can be increased when Surinabant is combined with Indalpine.
DB13950
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Indalpine.
DB14011
The risk or severity of adverse effects can be increased when Nabiximols is combined with Indalpine.
DB14043
The risk or severity of adverse effects can be increased when Palmidrol is combined with Indalpine.
DB14737
The risk or severity of adverse effects can be increased when Cannabinol is combined with Indalpine.
DB00191
The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Indalpine.
DB00852
The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Indalpine.
DB00907
The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Indalpine.
DB00915
The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Indalpine.
DB00951
The risk or severity of serotonin syndrome can be increased when Isoniazid is combined with Indalpine.
DB01079
The risk or severity of serotonin syndrome can be increased when Tegaserod is combined with Indalpine.
DB01191
The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Indalpine.
DB01255
The risk or severity of serotonin syndrome can be increased when Lisdexamfetamine is combined with Indalpine.
DB01365
The risk or severity of serotonin syndrome can be increased when Mephentermine is combined with Indalpine.
DB01467
The risk or severity of serotonin syndrome can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Indalpine.
DB01556
The risk or severity of serotonin syndrome can be increased when Chlorphentermine is combined with Indalpine.
DB01576
The risk or severity of serotonin syndrome can be increased when Dextroamphetamine is combined with Indalpine.
DB08167
The risk or severity of serotonin syndrome can be increased when Methylthioninium is combined with Indalpine.
DB09480
The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Iofetamine I-123.
DB12080
The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Ritobegron.
DB13108
The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Mephedrone.
DB13624
The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Methoxyphenamine.
DB13703
The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Gepefrine.
DB13910
The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Valproate bismuth.
DB00490
The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Indalpine.
DB12141
The therapeutic efficacy of Indalpine can be decreased when used in combination with Gilteritinib.
DB06480
The metabolism of Prucalopride can be decreased when combined with Indalpine.
DB00669
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Indalpine.
DB11823
The risk or severity of adverse effects can be increased when Indalpine is combined with Esketamine.
DB00395
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Indalpine.
DB12371
The risk or severity of adverse effects can be increased when Indalpine is combined with Siponimod.
DB00945
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Acetylsalicylic acid.
DB11921
The serum concentration of Indalpine can be increased when it is combined with Deflazacort.
DB00402
The risk or severity of CNS depression can be increased when Indalpine is combined with Eszopiclone.
DB00575
The risk or severity of sedation can be increased when Clonidine is combined with Indalpine.
DB00656
The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Indalpine.
DB00482
The risk or severity of bleeding can be increased when Celecoxib is combined with Indalpine.
DB05154
The serum concentration of Pretomanid can be increased when it is combined with Indalpine.
DB11986
The metabolism of Entrectinib can be decreased when combined with Indalpine.
DB12825
The serum concentration of Lefamulin can be increased when it is combined with Indalpine.
DB00924
The risk or severity of CNS depression can be increased when Indalpine is combined with Cyclobenzaprine.
DB01233
The risk or severity of sedation can be increased when Metoclopramide is combined with Indalpine.
DB01175
The risk or severity of serotonin syndrome can be increased when Escitalopram is combined with Indalpine.
DB11732
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Indalpine.
DB15444
The serum concentration of Elexacaftor can be increased when it is combined with Indalpine.
DB15035
The metabolism of Zanubrutinib can be decreased when combined with Indalpine.
DB14975
The serum concentration of Voxelotor can be increased when it is combined with Indalpine.
DB06119
The serum concentration of Indalpine can be decreased when it is combined with Cenobamate.
DB09237
The serum concentration of Levamlodipine can be increased when it is combined with Indalpine.
DB06077
The serum concentration of Indalpine can be increased when it is combined with Lumateperone.
DB15328
The serum concentration of Ubrogepant can be increased when it is combined with Indalpine.
DB00193
The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Indalpine.
DB00246
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Indalpine.
DB12457
The metabolism of Rimegepant can be decreased when combined with Indalpine.
DB00503
The serum concentration of Indalpine can be increased when it is combined with Ritonavir.
DB00502
The risk or severity of CNS depression can be increased when Haloperidol is combined with Indalpine.
DB11689
The serum concentration of Selumetinib can be increased when it is combined with Indalpine.
DB11652
The metabolism of Tucatinib can be decreased when combined with Indalpine.
DB15102
The metabolism of Pemigatinib can be decreased when combined with Indalpine.
DB00315
The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Indalpine.
DB00472
The risk or severity of serotonin syndrome can be increased when Fluoxetine is combined with Indalpine.
DB12674
The serum concentration of Lurbinectedin can be increased when it is combined with Indalpine.
DB00574
The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Indalpine.
DB12404
The risk or severity of sedation can be increased when Remimazolam is combined with Indalpine.
DB11932
The serum concentration of Indalpine can be increased when it is combined with Abametapir.
DB14881
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Indalpine is combined with Oliceridine.
DB15762
The serum concentration of Indalpine can be decreased when it is combined with Satralizumab.
DB14509
The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Lithium carbonate.
DB14506
The risk or severity of serotonin syndrome can be increased when Lithium hydroxide is combined with Indalpine.
DB14507
The risk or severity of serotonin syndrome can be increased when Lithium citrate is combined with Indalpine.

序列

实验性质

Melting Point
167
U.S. Patent 4,064,255.

外部标识符

resource：ChEBI
identifier：134939
resource：PubChem Compound
identifier：44668
resource：PubChem Substance
identifier：310264918
resource：ChemSpider
identifier：40643
resource：BindingDB
identifier：50029150
resource：Wikipedia
identifier：Indalpine
resource：ChEMBL
identifier：CHEMBL276520
resource：ZINC
identifier：ZINC000004674528

外部链接

路径

目标

酶

BE0002638Cytochrome P450 3A4HumanssubstrateinhibitorA3770024966680Gerotziafas GT, Mahe I, Elalamy I: New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients. Ther Clin Risk Manag. 2014 Jun 13;10:423-36. doi: 10.2147/TCRM.S49063. eCollection 2014.noCytochrome P450 3A4Vitamin d3 25-hydroxylase activityCytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide (PubMed:11159812). Catalyzes 4-beta-hydroxylation of cholesterol. May catalyze 25-hydroxylation of cholesterol in vitro (PubMed:21576599).CYP3A47q21.1Endoplasmic reticulum membrane2-228.2557342.677HumansHUGO Gene Nomenclature Committee (HGNC)HGNC:2637GenAtlasCYP3A4GenBank Gene DatabaseM18907Guide to Pharmacology1337UniProtKBP08684UniProt AccessionCP3A4_HUMAN1,8-cineole 2-exo-monooxygenase1.14.13.-Albendazole monooxygenaseAlbendazole sulfoxidaseCholesterol 25-hydroxylaseCYP3A3CYPIIIA3CYPIIIA4Cytochrome P450 3A3Cytochrome P450 HLpCytochrome P450 NF-25Cytochrome P450-PCN1Nifedipine oxidaseQuinine 3-monooxygenaseTaurochenodeoxycholate 6-alpha-hydroxylase>lcl|BSEQ0021936|Cytochrome P450 3A4 MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF DMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI AEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS MDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV FPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI IFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV NETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS KKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG GLLQPEKPVVLKVESRDGTVSGA>lcl|BSEQ0021937|Cytochrome P450 3A4 (CYP3A4) ATGGCTCTCATCCCAGACTTGGCCATGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG CTCCTCTATCTATATGGAACCCATTCACATGGACTTTTTAAGAAGCTTGGAATTCCAGGG CCCACACCTCTGCCTTTTTTGGGAAATATTTTGTCCTACCATAAGGGCTTTTGTATGTTT GACATGGAATGTCATAAAAAGTATGGAAAAGTGTGGGGCTTTTATGATGGTCAACAGCCT GTGCTGGCTATCACAGATCCTGACATGATCAAAACAGTGCTAGTGAAAGAATGTTATTCT GTCTTCACAAACCGGAGGCCTTTTGGTCCAGTGGGATTTATGAAAAGTGCCATCTCTATA GCTGAGGATGAAGAATGGAAGAGATTACGATCATTGCTGTCTCCAACCTTCACCAGTGGA AAACTCAAGGAGATGGTCCCTATCATTGCCCAGTATGGAGATGTGTTGGTGAGAAATCTG AGGCGGGAAGCAGAGACAGGCAAGCCTGTCACCTTGAAAGACGTCTTTGGGGCCTACAGC ATGGATGTGATCACTAGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA GACCCCTTTGTGGAAAACACCAAGAAGCTTTTAAGATTTGATTTTTTGGATCCATTCTTT CTCTCAATAATCTTTCCATTCCTCATCCCAATTCTTGAAGTATTAAATATCTGTGTGTTT CCAAGAGAAGTTACAAATTTTTTAAGAAAATCTGTAAAAAGGATGAAAGAAAGTCGCCTC GAAGATACACAAAAGCACCGAGTGGATTTCCTTCAGCTGATGATTGACTCTCAGAATTCA AAAGAAACTGAGTCCCACAAAGCTCTGTCCGATCTGGAGCTCGTGGCCCAATCAATTATC TTTATTTTTGCTGGCTATGAAACCACGAGCAGTGTTCTCTCCTTCATTATGTATGAACTG GCCACTCACCCTGATGTCCAGCAGAAACTGCAGGAGGAAATTGATGCAGTTTTACCCAAT AAGGCACCACCCACCTATGATACTGTGCTACAGATGGAGTATCTTGACATGGTGGTGAAT GAAACGCTCAGATTATTCCCAATTGCTATGAGACTTGAGAGGGTCTGCAAAAAAGATGTT GAGATCAATGGGATGTTCATTCCCAAAGGGGTGGTGGTGATGATTCCAAGCTATGCTCTT CACCGTGACCCAAAGTACTGGACAGAGCCTGAGAAGTTCCTCCCTGAAAGATTCAGCAAG AAGAACAAGGACAACATAGATCCTTACATATACACACCCTTTGGAAGTGGACCCAGAAAC TGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTTCAG AACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCCTGAAATTAAGCTTAGGAGGA CTTCTTCAACCAGAAAAACCCGTTGTTCTAAAGGTTGAGTCAAGGGATGGCACCGTAAGT GGAGCCTGAPF00067p450componentcytoplasmcomponentendoplasmic reticulum membranecomponentintegral component of membranecomponentintracellular membrane-bounded organellefunctionalbendazole monooxygenase activityfunctionaromatase activityfunctioncaffeine oxidase activityfunctionenzyme bindingfunctionheme bindingfunctioniron ion bindingfunctionmonooxygenase activityfunctionoxidoreductase activityfunctionoxygen bindingfunctionquinine 3-monooxygenase activityfunctionsteroid bindingfunctionsteroid hydroxylase activityfunctiontaurochenodeoxycholate 6alpha-hydroxylase activityfunctiontestosterone 6-beta-hydroxylase activityfunctionvitamin D 24-hydroxylase activityfunctionvitamin D3 25-hydroxylase activityprocessalkaloid catabolic processprocessandrogen metabolic processprocesscalcitriol biosynthetic process from calciolprocessdrug catabolic processprocessdrug metabolic processprocessexogenous drug catabolic processprocessheterocycle metabolic processprocesslipid metabolic processprocessmonoterpenoid metabolic processprocessoxidation-reduction processprocessoxidative demethylationprocesssmall molecule metabolic processprocesssteroid catabolic processprocesssteroid metabolic processprocessvitamin D metabolic processprocessxenobiotic metabolic processmoderate

载体

运输工具

药物反应

效应

不良反应